US20220154241A1 - Enzymatic circuits for molecular sensors - Google Patents

Enzymatic circuits for molecular sensors Download PDF

Info

Publication number
US20220154241A1
US20220154241A1 US17/586,772 US202217586772A US2022154241A1 US 20220154241 A1 US20220154241 A1 US 20220154241A1 US 202217586772 A US202217586772 A US 202217586772A US 2022154241 A1 US2022154241 A1 US 2022154241A1
Authority
US
United States
Prior art keywords
enzyme
circuit
polymerase
electrodes
molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US17/586,772
Inventor
Barry Merriman
Venkatesh Alagarswamy Govindaraj
Paul Mola
Tim Geiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roswell Me Inc
Original Assignee
Roswell Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/015,028 external-priority patent/US10508296B2/en
Application filed by Roswell Biotechnologies Inc filed Critical Roswell Biotechnologies Inc
Priority to US17/586,772 priority Critical patent/US20220154241A1/en
Publication of US20220154241A1 publication Critical patent/US20220154241A1/en
Assigned to WESTERN ALLIANCE BANK, AN ARIZONA CORPORATION reassignment WESTERN ALLIANCE BANK, AN ARIZONA CORPORATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Roswell Biotechnologies, Inc.
Assigned to Procopio, Cory, Hargreaves & Savitch LLP reassignment Procopio, Cory, Hargreaves & Savitch LLP SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Roswell Biotechnologies, Inc.
Assigned to Roswell ME Inc. reassignment Roswell ME Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Roswell Biotechnologies, Inc.
Assigned to Roswell ME Inc. reassignment Roswell ME Inc. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: Procopio, Cory, Hargreaves & Savitch LLP
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/002Electrode membranes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/48707Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721Investigating individual macromolecules, e.g. by translocation through nanopores
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6825Nucleic acid detection involving sensors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/10Nucleotidyl transfering
    • C12Q2521/101DNA polymerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60Detection means characterised by use of a special device
    • C12Q2565/607Detection means characterised by use of a special device being a sensor, e.g. electrode
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/91245Nucleotidyltransferases (2.7.7)
    • G01N2333/9125Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
    • G01N2333/9126DNA-directed DNA polymerase (2.7.7.7)

Definitions

  • the present disclosure is generally directed to molecular sensors and more particularly to molecular sensors in which an enzyme closes the circuit between two electrodes.
  • single molecule enzyme-based circuits wherein a single enzyme molecule is directly connected to a positive and negative electrode to form the circuit. These circuits are capable of yielding highly informative signals of enzyme activity. These improved signals have greater signal-to-noise levels such that the signals are more distinguishable from noise, and these improved signals include features that carry detailed information about the engagement between enzyme and the target substrate.
  • a molecular sensor comprises an enzyme-based molecular circuit (conductive pathway) such as described herein.
  • a sensor having a polymerase enzyme is usable to sense sequence information from a DNA template processed by the polymerase.
  • a molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes.
  • the enzyme of the circuit may comprise a first wiring point connected to the positive electrode and a second wiring point connected to the negative electrode.
  • the circuit may further comprise at least one arm molecule having first and second ends, the first end bonded to the enzyme and the second end bonded to at least one of the electrodes, wherein the at least one arm molecule acts as an electrical wire between the enzyme and at least one of the electrodes.
  • the at least one arm molecule may be selected from the group consisting of a double stranded oligonucleotide, a peptide nucleic acid duplex, a peptide nucleic acid-DNA hybrid duplex, a protein alpha-helix, a graphene-like nanoribbon, a natural polymer, a synthetic polymer, and an antibody Fab domain.
  • At least one of the electrodes is connected to an internal structural element of the enzyme.
  • the internal structural element may be selected from the group consisting of an alpha-helix, a beta-sheet, and a multiple of such elements in series.
  • At least one of the electrodes may be connected to the enzyme at a location of the enzyme capable of undergoing a conformational change.
  • At least one arm molecule may comprise a molecule having tension, twist or torsion dependent conductivity.
  • the enzyme may comprise a polymerase.
  • the polymerase comprises E. coli Pol I Klenow Fragment.
  • the polymerase comprises a reverse transcriptase.
  • the polymerase comprises a genetically modified reverse transcriptase.
  • a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme comprising E. coli Pol I Klenow Fragment connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the polymerase at connection points within the major alpha-helix of the polymerase extending between amino acids at position 514 and 547.
  • a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the sensor is usable to sense sequence information from a DNA template processed by the polymerase.
  • a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the polymerase at connection points on the thumb and finger domains of the polymerase, and wherein such points undergo relative motion in excess of 1 nanometer as the polymerase processes a DNA template.
  • the polymerase in this sensor is engineered to have extended domains which produce a greater range of relative motion as the polymerase processes a DNA template.
  • the polymerase in this sensor is engineered to have additional charge groups that variably influence the internal conduction path as the enzyme processes a DNA template.
  • the polymerase in this circuit is a genetically modified form of E. coli. Pol I, Bst, Taq, Phi29, or T7 DNA polymerases, or a genetically modified reverse transcriptase.
  • a molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the enzyme at connection points in the enzyme comprising at least one of a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner.
  • this circuit further comprises a gate electrode.
  • a method of sequencing a DNA molecule comprises: providing a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes; initiating at least one of a voltage or a current through the circuit; exposing the circuit to a solution containing primed single stranded DNA and/or dNTPs; and measuring electrical signals through the circuit as the polymerase engages and extends a template, wherein the electrical signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
  • a method of molecular detection comprises, providing a circuit further comprising: a positive electrode; a negative electrode spaced apart from the positive electrode; a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes and a gate electrode; initiating at least one of a voltage or a current through the circuit; exposing the circuit to at least one of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode; and measuring an electrical change in the circuit.
  • FIG. 1 illustrates the general concept of a molecular electronic circuit
  • FIG. 2 illustrates the general concept of engaging an enzyme to a molecular electronic circuit, such as to act as a sensor of enzyme activity with its target;
  • FIG. 3 illustrates an enzyme that is wired directly into the current path, in accordance with various embodiments
  • FIG. 4 illustrates an enzyme that is wired directly into the current path, with the connection made to an internal alpha-helix structure within the enzyme, in accordance with various embodiments
  • FIG. 5 illustrates an enzyme that is wired directly into the current path, with the connection made to a series of two or more internal alpha-helix structures in series within the enzyme, in accordance with various embodiments;
  • FIG. 6 illustrates an enzyme that is wired directly into the current path, with the connection made to an internal beta-sheet structure within the enzyme, in accordance with various embodiments
  • FIG. 7 illustrates an enzyme that is wired directly into the current path, such that connections are made to points of conformational change in the enzyme, to induce tension changes into the circuit during enzyme activity;
  • FIG. 8 illustrates an enzyme that is wired directly into the current path, with additional connections made to stabilize the position of the enzyme
  • FIG. 9 illustrates a schematic of an enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein the enzyme directly couples to the electrodes without the use of arm molecules;
  • FIG. 10 illustrates a schematic of an enzyme directly wired by two points of contact into a circuit, as well as also having a one-point conjugation to a molecular wire, utilizing one pair of electrodes to measure the combined conduction, in accordance with various embodiments;
  • FIG. 11 illustrates a schematic of an enzyme directly wired by two points of contact into a circuit, as well as also having a one-point conjugation to a molecular wire, utilizing two pairs of electrodes to measure these two modes of conduction independently, in accordance with various embodiments;
  • FIG. 12 illustrates a protein structure view of the E. coli Pol I Klenow Fragment Polymerase enzyme, illustrating the presence of alpha-helix, beta-sheet, and connecting loop structures;
  • FIG. 13 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein a specific alpha-helix is used for the contacts, and molecular arms provide coupling to the electrodes;
  • FIG. 14 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein a specific alpha-helix is used for the contacts, and the polymerase directly couples to the electrodes without the use of arm molecules;
  • FIG. 15 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein arms are wired to the points that undergo relative motion when the finger and thumb domains change relative conformation;
  • FIG. 16 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, and where additional connecting arms are wired to provide stabilization and fixed spatial orientation.
  • a molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes.
  • the enzyme comprises a first wiring point connected to the positive electrode and a second wiring point connected to the negative electrode.
  • enzyme means a molecule that acts to transform another molecule, by engaging with a variety of substrate molecules. Such transformation could include chemical modification, or conformational modification.
  • Common biological enzyme classes are polymerases, ligases, nucleases, kinases, transferases, as well as genetically modified forms of these molecules.
  • Polymerases herein include reverse transcriptases and any genetically modified reverse transcriptase, capable of directly acting on an RNA template.
  • Enzymes are most commonly proteins, but may be composed of multiple amino acid chains, and may also be complexed with other types of molecules, such as RNA in the case of the ribosome enzyme.
  • the term “substrate” for an enzyme refers to any of the molecules that the enzyme specifically engages with in the course of performing a transformation.
  • the substrate in the specific case of a DNA polymerase, the substrate consists of both a template DNA and dNTPs.
  • the enzyme may also complex with various co-factors that moderate its function or kinetics.
  • divalent cations such as Mg++ are often essential cofactors, but not considered as substrates.
  • dNTP or “dNTPs” refers to any of the deoxynucleotide triphosphates involved in polymerase-based DNA synthesis, or that can be engaged for such DNA synthesis, including both native and modified forms of such molecules.
  • buffer for an enzyme refers to a solution in which the enzyme is viable and functional, and typically containing the substrates and co-factors needed for enzyme activity.
  • Such an enzyme buffer may typically comprise salts, detergents, and surfactants, singly or in various combinations, as well as specific cofactors, such as magnesium or other divalent cations for a polymerase enzyme, along with the substrates, such as DNA and dNTPs for a polymerase enzyme.
  • Such a buffer herein may have its composition modified from standard forms, such as to enhance signal properties in a sensor exposed to the buffer.
  • Electrode means any structure that can act as an efficient source or sink of charge carriers. Most commonly these would be metal or semiconductor structures, such as those used in electronic circuits.
  • a pair of spaced apart electrodes herein may comprise a source and drain electrode pair.
  • a binding probe-based molecular circuit may further comprise a gate electrode.
  • a gate electrode is used to apply a voltage rather than transfer charge carriers. Thus it supports accumulation of charge carriers to produce a local electric field, but is not intended to pass current.
  • a gate electrode will be electrically isolated from the primary conduction paths of the circuit by some form of insulating layer or material.
  • conjugation means any of the wide variety of means of physically attaching one molecule to another, or to a surface or particle. Such methods typically involve forming covalent or non-covalent chemical bonds, but may also rely on protein-protein interactions, protein-metal interactions, or chemical or physical adsorption via intermolecular (Van der Waals) forces. There is a large variety of such methods know to those skilled in the art of conjugation chemistry. Common conjugation methods relevant to preferred embodiments herein include thiol-metal bonds, maleimide-cysteine bonds, material binding peptides such as gold binding peptides, and click chemistries.
  • an electrical current may be initiated in a circuit.
  • Such initiating of a current may be the result of applying a voltage to the circuit, but may be from other actions to the circuit besides applying a voltage.
  • a voltage may be initiated in a circuit.
  • Such initiating of a voltage may be the result of applying a current to the circuit, but may be from other actions to the circuit besides applying an electrical current.
  • a voltage or a current may be initiated in one portion of a circuit as the result of applying a voltage or a current to the overall circuit.
  • a flow of electrons initiated from a negative to a positive electrode in a circuit of the present disclosure may be controlled by the voltage applied to the gate electrode of the circuit.
  • a molecular sensor comprises an enzyme connected to both a positive and a negative electrode to complete a circuit. Interactions of the enzyme with various substrates are detectable as changes in the current or other electrical parameter measured across the circuit.
  • the present molecular sensor differs from the general concept of a molecular electronic circuit in that the enzyme is directly “wired” to both the positive and negative electrodes rather than bonded to a molecular bridge molecule that spans the gap between the electrodes to complete a circuit.
  • At least one of a voltage or a current is initiated in an enzyme-based molecular circuit.
  • electrical changes in the circuit are sensed. These electrical changes, or informative electrical signals, may include current, voltage, impedance, conductivity, resistance, capacitance, or the like.
  • a voltage is initiated in the circuit and then changes in the current through the circuit are measured as substrates interact with the enzyme.
  • a current is initiated in the circuit, and changes to voltage in the circuit are measured as substrates interact with the enzyme.
  • impedance, conductivity, or resistance is measured.
  • the circuit further comprises a gate electrode, such as positioned underneath the gap between the positive and negative electrodes, at least one of a voltage or current may be applied to the gate electrode, and voltage, current, impedance, conductivity, resistance, or other electrical change in the circuit may be measured as substrates interact with the enzyme.
  • FIG. 1 illustrates the general concept of a molecular electronic circuit having a bridge molecule 10 attached to and bridging the gap 12 between electrodes 15 , as well as some type of conjugation group 20 or other mechanism that binds the molecule to the electrodes (depicted as small shaded squares).
  • FIG. 1 further illustrates that a current, (i), may pass through this molecule and be measured versus time, (t), as shown in the inset plot 25 .
  • FIG. 2 illustrates a molecular electronic sensor in which an enzyme 30 is conjugated to the molecular bridge component 31 spanning the electrodes 32 , wherein monitoring the current provides a sensor for the enzyme engaging with and processing its target substrate 35 when exposed to a suitable buffer solution.
  • the local charge perturbations that result from the target substrate engaging with the enzyme perturb charge transport through the primary bridge component, and are thus registered as a change in conductivity or current versus time, as indicated by the step-up change in the current (i) vs. time (t) current plot inset 38 in FIG. 2 .
  • a molecular sensor comprises a single enzyme molecule directly wired into the circuit path, such that all electrical current passing through the molecular circuit must flow through the enzyme.
  • the enzyme is an essential conduction path in the circuit, like an electronic component on a circuit board.
  • FIG. 3 shows an enzyme 42 connected between molecular arms 40 .
  • the enzyme may be coupled to both positive and negative electrodes at two or more points, such as to ensure that charge carriers traversing the molecular structure pass into and out of the enzyme.
  • two molecular arms are conjugated to the enzyme to provide physical anchors and entry and exit paths for the current through the enzyme.
  • Such arms may comprise any convenient molecule that provides a conducting connection or semi-conducting connection between the enzyme and the electrodes.
  • molecular arms may provide spanning length extensions, to help span a larger electrode gap 55 that is wider than the 3D structure of the enzyme.
  • Such arms may also provide the advantage of keeping the enzyme away from contacting the electrodes 65 where unfavorable or damaging interactions may occur with the electrodes, such as a denaturing adsorption to the electrode.
  • Such arms may also provide for more compatible or efficient coupling to the electrodes, such as by coupling to the electrodes via chemical groups that are not readily found or made available on the enzyme.
  • the electrode comprises gold and the molecular arm includes a thiol group, such that the arm couples to the gold electrode via well-known thiol-gold binding.
  • the molecular arm accomplishes the binding while the enzyme may not have such available thiol groups.
  • the arms may present a click-chemistry binding group, for coupling to electrodes that are derivatized with the cognate binding partners for the click chemistry.
  • molecular arms comprise some form of conjugation 60 to the enzyme, as well as their conjugations or couplings to the electrodes.
  • conjugation comprises chemical crosslinking, which can preferentially couple suitable chemical groups on the arms to amino acid residues on the enzyme.
  • a maleimide group on the arm couples to a surface cysteine on the enzyme.
  • genetically modified versions of an enzyme may be created and employed, such as enzymes comprising specific amino acids or protein domains engineered into their amino acid structure that provide specific conjugation sites. For example, cysteine amino acids engineered at specific sites on the enzyme provide for the attachment point of arms that present a maleimide group.
  • one or more native cysteines that would provide competing arm binding sites may be “engineered out” of the amino acid sequence. If not all such sites can be removed, it is possible to use various purification methods from synthetic chemistry to isolate desired enzyme-arm conjugates from unwanted configurations.
  • genetic methods are used to engineer into the amino acid sequence of the enzyme amino acids comprising residues that uniquely conjugate to a cognate group on the arms. This variation includes cases where non-standard amino acids are employed, such as amino acids modified to present a click-chemistry group, via protein expression systems that use a modified genetic code and modified transfer RNAs to put non-native amino acids at specific sequence sites in an expressed enzyme protein.
  • a peptide domain that specifically binds with a cognate group on the arms is engineered into the sequence of a protein enzyme.
  • a peptide that is an antigen to an antibody is engineered into the enzyme, and the Fab binding domain of the antibody is used on the arms.
  • One such embodiment is to use the FLAG peptide motif DYKDD, and any suitable ANTI-FLAG Fab domain. Any other peptide antigens and their cognate Fab domains can similarly be used to conjugate arms to specific sites in an engineered enzyme protein, by engineering the peptide antigen into the desired conjugation sites on the enzyme.
  • peptide domains make use of the SPY-TAG/SPY-CATCHER protein-protein binding system, by engineering either the SPY-TAG domain or the SPY-CATCHER domain into the enzyme protein, and placing the cognate domain in the arms.
  • another embodiment is to add short linker peptide sequences flanking the target peptide, to enhance the availability of the domain for binding.
  • short linkers may comprise short glycine and serine rich linkers, as are known to those skilled in the art of protein engineering, including, but not limited to, the linker amino acid sequences G, GS, GSG, GGSG, etc.
  • the arm molecules comprise any molecules that provide for conduction of charge carriers into and out of the enzyme.
  • such arms comprise molecular wires from the many forms known in field of molecular electronics, functionalized with suitable conjugation and binding groups for wiring to electrodes and enzyme.
  • such arms may comprise single stranded DNA, double stranded DNA, peptides, peptide alpha-helices, antibodies, Fab domains of antibodies, carbon nanotubes, graphene nanoribbons, natural polymers, synthetic polymers, other organic molecules with p-orbitals for electron delocalization, or metal or semiconductor nanorods or nanoparticles.
  • the arms may comprise double stranded DNA with thiol-bearing groups at one end, and maleimide at the other end that couples to the enzyme, or a peptide alpha-helix with a cysteine or gold binding peptide at one termini, and a maleimide at the other end that couples to the enzyme, or a graphene nanoribbon with thiol-bearing groups at one end, and a maleimide bearing group at the other end that couples to the enzyme.
  • the two arm molecules used to couple an enzyme to two electrodes are identical molecules, and in other embodiments, the two arm molecules are different molecules.
  • there may be a “positive electrode” arm and a “negative electrode” arm providing for oriented binding of an enzyme to the corresponding “positive” and “negative” electrodes in FIG. 3 .
  • arm conjugation points connect directly to specific protein structural elements within the enzyme.
  • FIG. 4 A non-limiting example is illustrated in FIG. 4 , where the arms 75 are shown wired directly to an alpha-helix structure 70 in the enzyme 72 .
  • Such structural elements provide preferential conduction paths through the enzyme.
  • Direct wiring to natural conduction paths in the enzyme guide current closer to active regions of interest within the enzyme, such as substrate binding pockets, and may thereby provide for further enhanced current signals, or current signals that carry more information on enzyme-substrate interactions.
  • FIG. 4 one embodiment is shown in FIG. 4 , where the arms wire directly to an alpha-helix that spans between two points on or near the surface of the enzyme. Another example is shown in FIG.
  • a protein enzyme will have a 3D structure that includes well known secondary structural elements such as alpha-helices and beta-sheets. These are primarily hydrogen bonded structures that can provide discrete conduction paths through the body of the enzyme, to the extent that current carriers, such as electrons, may efficiently hop along such structures, or along the hydrogen bonds that define such structures, with less resistance than otherwise hopping or tunneling off such structures. These structures provide preferential conduction paths that will channel charge carriers, and by selecting such structures, charge is forced to pass close to active regions of the enzyme, and current-based sensing of the activity will be improved.
  • the wiring can be to such structures that appear in the enzyme “in series”, such as for example, two alpha-helices in series as indicated in FIG. 5 , or a beta-sheet in series with an alpha-helix, or three successive alpha-helices.
  • each successive element in series appears in the enzyme primary amino acid sequence as separated from the previous element by a small number of amino acids, such 0, 1, 2, or up to approximately 10 amino acids, which typically form a connecting loop in the secondary structure.
  • Wiring of elements in series may also be achieved by wiring to structures that are not contiguous in the primary amino acid sequence of the enzyme, but are nonetheless spatially contiguous and in conductive contact, and form a preferred conduction path, owing to hydrogen bonding, salt bridges, disulfide bridges, or other types of molecular interaction that establish secondary, tertiary or quaternary protein structure and that can provide a clearly defined and favorable conduction path from one structural element (beta-sheet, alpha-helix) to another.
  • These structural elements of interest for wiring are most evident when examining the 3D structure of the proteins involved, as can be observed from the crystal structures, and in particular, by examination of the protein structures obtained by X-ray or NMR crystallography. This useful form of structural information is illustrated by the polymerase enzyme structure shown in FIG. 12 .
  • the arms are wired to points on the enzyme that undergo conformation changes or relative motion during enzyme function, such as illustrated in FIG. 7 .
  • the arms 105 are wired to two points 110 that are indicated as having relative motion, as illustrated in the inset 108 , during enzyme activity.
  • This configuration can enhance signaling by several means. First, such motions can change the tension in the arms, and it is known that tension changes in molecules can change their conductivity, thus the motion may be transduced via tension into a change in conductivity of the arms, which consequently show up in the current signals. In this way, the current may contain information about the conformational changes in the enzyme. Second, similarly, this configuration can cause tension in the enzyme as it changes conformation, and thus alter conductivity of the enzyme.
  • an enzyme is engineered to have extended regions that undergo greater conformational change or relative motion (e.g. as demonstrated by extending the length of the two tips of the scissor-shaped enzyme indicated in FIG. 7 ), so as to enhance the range of motion, and therefore the range of tension changes in the arms and enzymes.
  • conformational changes in the enzyme are translated into a twist, torque or rotation of at least one arm, and that twist, torsion or rotation alters the conductivity of the arm.
  • an arm comprising an organic polymer further comprising polycyclic aromatic rings, such as polythiophene or polyphenylene, whereby previously lined up p-orbitals are rotated out of alignment by C—C bond rotation when the arm is twisted, torqued or rotated in response to an enzyme conformational change.
  • the electrons have impeded delocalization through the organic polymer.
  • such impeded flow may act on only a subset of the charge carriers, depending on, for example, the polarization or other quantum state of the charge carrier, such as spin polarization of an electron charge carrier, or the momentum or energy state of the charge carrier.
  • the molecular sensor circuit comprises more than two arms, for example, 3 arms (the first arm 115 , the second arm 116 , and the third arm 117 ).
  • additional arms may also provide stabilization, impose a spatial orientation (such as to orient an active site), or otherwise reduce physical degrees of freedom or conformational entropy, which may improve sensing by reducing the variability in conduction that comes from the system having more accessible conformations.
  • Such additional arms may be conductive, but they can also be insulating if they are present primarily to provide stability, orientation, or reduction in spatial degrees of freedom.
  • Such additional arms may connect to the electrode, or to other portions of the structure, such as to a substrate supporting the electrodes.
  • Such arms may connect to additional electrodes in a system comprising more than two electrodes, including the case of a system with a gate electrode, such as a buried gate electrode.
  • Connection to a gate electrode may refer to connection to the conductive portion of the gate, or connection to the insulating layer that separates actual conductive gate from the circuit, or, in the case of a buried gate, the surface layer above the buried gate, such as the connection to the surface illustrated in FIG. 16 .
  • the enzyme may be connected to the electrodes directly 120 , as an essential conduction path, without the use of arm molecules.
  • groups on the enzyme directly couple to the electrodes.
  • one wiring connection comprises direct coupling to the enzyme, the other via an arm molecule.
  • a sensor comprising a directly wired enzyme as an essential conduction path may have its signal performance enhanced through various environmental factors.
  • the choice of buffer, buffer additives, temperature and applied voltage may be modulated to improve the signal quality.
  • enzymes may complex with various cofactors that modulate their kinetics, and the salt levels in the buffer also impact enzyme kinetics, as does temperature, these factors may be used to improve signaling performance.
  • the overall ionic strength of the buffer solution defines the Debye length in the solution, that is the distance over which electric fields extend in solution, and can impact the extent to which current carriers passing through the enzyme are influenced by the charge distributions of the enzyme and substrate, and thus buffer ionic strength or total salt concentration is another means of influencing or enhancing the signaling.
  • the divalent cation content of the buffer is known to influence enzyme activity, and the choice of divalent cation, for example from among Mg++, Mn++, Ni++, Zn++, Co++, Ca++, Cr++, and their concentration may be optimized to improve the signaling from a polymerase wired as an essential conduction path.
  • the applied driving voltage may be optimized to improve the signaling from an enzyme wired as an essential conduction path. Based on energy barriers within the enzyme, certain voltages may lead to improved signaling performance.
  • various embodiments may also have a gate electrode, such as a buried gate below the lower substrate indicated in FIG. 3 , such that voltages applied to the gate electrode further modulate the signaling properties of the enzyme circuit.
  • Certain embodiments may employ voltage spectroscopy, wherein the driving or gate voltages are swept through a range of values, and the signal of interest is in the response from this sweep, which contains information on the interaction between the enzyme and its substrates.
  • the molecular circuit sensors of the present disclosure comprise the wiring of an enzyme with at least two points of electrical contact, so as to make the enzyme an essential conduction path, in contrast to the configuration of FIG. 2 .
  • Two-point wiring of the enzyme may be combined with a conjugation 125 to one or more molecular arms 127 , as shown in FIGS. 10 and 11 .
  • the current can be both driven through the enzyme, for sensing, and the enzyme can also modulate current through the other molecular wire, as an additional sensing mode.
  • these conduction modes are monitored by a single electrode pair 130 , and combine to produce a single current, whereas in FIG.
  • the senor may comprise an enzyme 126 wired up with two or more points of contact as a conduction path, in conjunction with additional sensor configuration features. Wiring the enzyme at two points, with input and output electrical contacts, can provide enhanced signaling. Other possible and non-limiting configurations are illustrated in FIGS. 10 and 11 .
  • a molecular circuit sensor comprises a polymerase enzyme.
  • FIG. 12 shows a representative polymerase enzyme 150 , the Klenow Fragment of E. coli DNA Polymerase I.
  • FIG. 12 illustrates a ribbon diagram of the enzyme structure, from two different views, with the enzyme engaged with a double-stranded DNA template 170 .
  • the enzyme primary structure is a single amino acid sequence of 605 amino acids.
  • the secondary structure and tertiary structure of the enzyme are depicted in FIG. 12 .
  • This figure shows the structural elements of the enzyme. In particular, there are 28 distinct alpha-helix elements 160 , and two major beta-sheet elements 165 , separated by short flexible loop segments 155 .
  • Such structural elements are similarly present in other types of polymerases and other enzyme proteins in general. In the course of enzyme activity, these structural features engage in electrical, chemical, mechanical and conformational perturbations, and wiring to these features within an electrical circuit can transduce these perturbations into measured signals.
  • FIG. 13 shows an embodiment where the polymerase 177 is wired as an essential conduction path, and specifically wired to the ends of a long alpha-helix 180 that passes through the center of the enzyme.
  • This alpha-helix was chosen because it passes very near to the active pocket of the polymerase, and therefore can provide for enhanced current sensing of the polymerase activity as it binds to a primed strand and extends the primer through incorporation of dNTPs.
  • Other alpha-helices in the structure will provide other sensing opportunities, and other embodiments comprise wiring to such alpha-helix structures, or the beta-sheet structures, or other such structures occurring in series.
  • the arms may comprise double stranded oligonucleotides terminated with a maleimide, which couples to a cysteine genetically engineered into a precise location in a mutant form of the polymerase.
  • the arms comprise a protein alpha-helix terminated with a maleimide which couples such a cysteine.
  • cysteine (C) placed at the conjugation points indicated in FIG. 3 , which arise from replacing the glutamine (Q) at amino acid position 548 by C, and replacing the serine (S) at amino acid position 508 by C, and these two locations lie just outside and bracket a single long (37 amino acid) alpha-helix that extends from amino acid position 514 to 547.
  • the mutant polymerase further has the single native C at amino acid position 584 replaced by a non-cysteine, such as S, so as to provide exactly the two sites for coupling of the maleimide terminated arms, via the well-known maleimide-cysteine conjugation.
  • a non-cysteine such as S
  • Making such amino acid substitutions to introduce cysteines should be done in a manner that does not alter highly conserved amino acids (as conserved in comparison to other polymerases), does not alter amino acids in the alpha-helix or other structural elements that are the target of the wiring, does not alter amino acids directly participating in critical enzyme function, such as those that interact directly with the structure of the substrate binding pocket, the DNA substrate or the dNTP substrates. Similar selection principles apply to other enzymes as well when mutating in cysteine as a maleimide conjugation point.
  • FIG. 14 illustrates an alternative embodiment where the mutant polymerase 177 of FIG. 13 is directly conjugated 185 to the electrodes 187 , coupling to the internal alpha-helix, without the use of connecting arms.
  • This coupling can be achieved, for example, by utilizing gold electrodes, and a gold-binding peptide (GBP) with a maleimide terminus, such that the maleimide conjugates the GBP to the mutant polymerase at the cysteine sites described above, and the GBP conjugates to the gold electrode, thereby wiring in the polymerase via these two cysteine sites.
  • GBP gold-binding peptide
  • Other embodiments of direct maleimide-mediated conjugations to the electrodes are enabled by using conjugating groups having the form X-maleimide bonded to the cysteines on the polymerase, such that X is a group that then binds to the electrode surface.
  • FIG. 15 illustrates an alternative embodiment, where the mutant polymerase 177 of FIG. 13 is wired to the electrodes 212 using connecting arms 210 through an alpha-helix 200 adjacent to the binding cleft 205 of the polymerase.
  • the connecting arms are wired to two points 215 on the polymerase. In embodiments, these two points have the ability to move relative to each other, thereby allowing for changes in conductivity and enhanced signaling.
  • FIG. 16 illustrates an embodiment in which multiple arms 190 are used to wire up the polymerase 195 as an essential conducting path, as well as to stabilize its position and orientation relative to the electrodes and substrate.
  • the lower pair of arms indicated can be either conducting or insulating, in accordance with various embodiments.
  • a circuit comprises an enzyme wired in as an essential conduction path.
  • the circuit may comprise first and second wiring points, connecting to a first and a second electrode such as a positive electrode and a negative electrode.
  • the circuit may further comprise at least one arm molecule having two ends, one end bonded to the enzyme and the other end bonded to at least one of the electrodes, wherein the at least one arm molecule acts as an electrical wire between the enzyme molecule and at least one of the electrodes.
  • an arm molecule may be selected from the group consisting of a double stranded oligonucleotide, a peptide nucleic acid (PNA) duplex, a PNA-DNA hybrid duplex, a protein alpha-helix, a graphene-like nanoribbon, a natural polymer, a synthetic organic molecule e.g. a synthetic polymer, and an antibody Fab domain.
  • the enzyme is wired directly to the electrodes without the use of any arm molecules.
  • the wiring may be to an internal structural element in the enzyme, such as an alpha-helix, or a beta sheet, or multiple such elements in series.
  • a circuit comprises an enzyme wired at points that undergo relative conformational change.
  • arms comprise molecules that have a tension dependent conductivity.
  • arm molecules may have torsion or twist dependent conductivity. Additional wiring points may be used to couple the enzyme at additional sites.
  • a circuit comprises a polymerase enzyme, such as for example, E. coli Pol I Klenow Fragment, wherein the wiring is to the major alpha-helix extending between amino acids at position 514 and 547.
  • a polymerase enzyme such as for example, E. coli Pol I Klenow Fragment
  • Such connection may rely on the placement of genetically engineered cysteines at or near these amino acid positions.
  • Circuits comprising a polymerase may be used to sense sequence information from a DNA template processed by the polymerase.
  • a circuit in accordance to various embodiments of the present disclosure may be exposed to a solution containing primed single stranded DNA, and/or dNTPs, wherein the current through the circuit is measured as the polymerase engages and extends a template, and the resulting signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
  • connection between the enzyme molecule and at least one of the positive electrode and negative electrode may comprise any one of: a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner.
  • the wiring is to points on the thumb and finger domain of the enzyme, where such points undergo relative motion in excess of 1 nm as the polymerase processes a DNA template.
  • the polymerase is engineered to have extended domains that produce a greater range of relative motion as the polymerase processes a DNA template. For example, conformational changes in an enzyme may be accentuated by extending various domains in the enzyme.
  • a polymerase enzyme may also be engineered to have additional charge groups that variably influence the internal conduction path as the enzyme processes a DNA template.
  • a circuit is exposed to a solution comprising modified dNTPs that variably influence the internal conduction path as the enzyme processes a DNA or RNA template.
  • the polymerase enzyme is a genetically modified form of one of: E. coli. Pol I polymerase, Bst polymerase, Taq polymerase, Phi29 polymerase, T7 polymerase, and reverse transcriptase.
  • a circuit is exposed to one or more of the conditions of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode.
  • the polymerase enzyme comprises a reverse transcriptase or genetically modified reverse transcriptase, capable of directly acting on an RNA template.
  • a reverse transcriptase in these circuits has the benefit that the reverse transcriptase can directly process an RNA template, and therefore provide a means for directly sequencing RNA molecules.
  • this reverse transcriptase could be any monomeric reverse transcriptase or a genetically modified form thereof, such as Moloney murine leukemia virus reverse transcriptase, porcine endogenous retrovirus reverse transcriptase, bovine leukemia virus reverse transcriptase, mouse mammary tumor virus reverse transcriptase, or a heterodimeric reverse transcriptase such as human immunodeficiency virus reverse transcriptase or Rous sarcoma virus reverse transcriptase.
  • a monomeric reverse transcriptase such as Moloney murine leukemia virus reverse transcriptase, porcine endogenous retrovirus reverse transcriptase, bovine leukemia virus reverse transcriptase, mouse mammary tumor virus reverse transcriptase, or a heterodimeric reverse transcriptase such as human immunodeficiency virus reverse transcriptase or Rous sarcoma virus reverse transcriptase.
  • a method of sequencing a DNA molecule comprises: providing an enzyme-based molecular circuit having spaced-apart positive and negative electrodes and a polymerase enzyme molecule connected to both the positive and negative electrodes to form a conductive pathway between the electrodes; initiating at least one of a voltage or a current through the circuit; exposing the circuit to a solution containing primed single stranded DNA and/or dNTPs; and measuring electrical signals through the circuit as the polymerase engages and extends a template, wherein the electrical signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
  • a method of molecular detection comprises: (a) providing an enzyme-based molecular circuit having spaced-apart positive and negative electrodes, a polymerase enzyme molecule connected to both the positive and negative electrodes to form a conductive pathway between the electrodes, and a gate electrode; (b) initiating at least one of a voltage or a current through the circuit; (c) exposing the circuit to at least one of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode; and (d) measuring an electrical change in the circuit.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electrochemistry (AREA)
  • Cell Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

In various embodiments a molecular circuit is disclosed. The circuit comprises a negative electrode, a positive electrode spaced apart from the negative electrode, and an enzyme molecule conductively attached to both the positive and negative electrodes to form a circuit having a conduction pathway through the enzyme. In various examples, the enzyme is a polymerase. The circuit may further comprise molecular arms used to wire the enzyme to the electrodes. In various embodiments, the circuit functions as a sensor, wherein electrical signals, such as changes to voltage, current, impedance, conductance, or resistance in the circuit, are measured as substrates interact with the enzyme.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 16/015,028 filed Jun. 21, 2018 and entitled “Enzymatic Circuits for Molecular Sensors.” The '028 Application is a continuation of PCT Application No. PCT/US18/29382, filed on Apr. 25, 2018 entitled “Enzymatic Circuits for Molecular Sensors,” which claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 62/489,881 filed Apr. 25, 2017 and entitled “Enzymatic Circuits for Molecular Sensors,” the disclosures of which are incorporated herein by reference in their entirety.
  • FIELD
  • The present disclosure is generally directed to molecular sensors and more particularly to molecular sensors in which an enzyme closes the circuit between two electrodes.
  • BACKGROUND
  • The broad field of molecular electronics was introduced in the 1970's by Aviram and Ratner. Molecular electronics achieves the ultimate scaling down of electrical circuits by using single molecules as circuit components. Molecular circuits comprising single molecule components can function diversely as switches, rectifiers, actuators and sensors, depending on the nature of the molecule. Of particular interest is the application of such circuits as sensors, where molecular interactions provide a basis for single molecule sensing. In particular, informative current changes could include an increase, or decrease, a pulse, or other time variation in the current.
  • Notwithstanding the achievements in the field of molecular electronics, new molecular circuits that can function as molecular sensors are still needed. In particular, the need still exists for improved single molecule systems that can yield molecular information with greater signal-to-noise ratios such that signals truly indicative of molecular interactions are distinguishable from non-informative noise.
  • SUMMARY
  • In various embodiments, single molecule enzyme-based circuits are disclosed wherein a single enzyme molecule is directly connected to a positive and negative electrode to form the circuit. These circuits are capable of yielding highly informative signals of enzyme activity. These improved signals have greater signal-to-noise levels such that the signals are more distinguishable from noise, and these improved signals include features that carry detailed information about the engagement between enzyme and the target substrate.
  • In various embodiments, a molecular sensor comprises an enzyme-based molecular circuit (conductive pathway) such as described herein. Such a sensor having a polymerase enzyme is usable to sense sequence information from a DNA template processed by the polymerase.
  • In various embodiments of the present disclosure, a molecular circuit is disclosed. The circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes.
  • In various aspects, the enzyme of the circuit may comprise a first wiring point connected to the positive electrode and a second wiring point connected to the negative electrode.
  • In various aspects, the circuit may further comprise at least one arm molecule having first and second ends, the first end bonded to the enzyme and the second end bonded to at least one of the electrodes, wherein the at least one arm molecule acts as an electrical wire between the enzyme and at least one of the electrodes.
  • In various aspects, the at least one arm molecule may be selected from the group consisting of a double stranded oligonucleotide, a peptide nucleic acid duplex, a peptide nucleic acid-DNA hybrid duplex, a protein alpha-helix, a graphene-like nanoribbon, a natural polymer, a synthetic polymer, and an antibody Fab domain.
  • In various aspects, at least one of the electrodes is connected to an internal structural element of the enzyme.
  • In various aspects, the internal structural element may be selected from the group consisting of an alpha-helix, a beta-sheet, and a multiple of such elements in series.
  • In various aspects, at least one of the electrodes may be connected to the enzyme at a location of the enzyme capable of undergoing a conformational change.
  • In various aspects, at least one arm molecule may comprise a molecule having tension, twist or torsion dependent conductivity.
  • In various aspects, the enzyme may comprise a polymerase.
  • In various aspects, the polymerase comprises E. coli Pol I Klenow Fragment.
  • In various aspects, the polymerase comprises a reverse transcriptase.
  • In various aspects, the polymerase comprises a genetically modified reverse transcriptase.
  • In various aspects, a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme comprising E. coli Pol I Klenow Fragment connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the polymerase at connection points within the major alpha-helix of the polymerase extending between amino acids at position 514 and 547.
  • In various aspects, a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the sensor is usable to sense sequence information from a DNA template processed by the polymerase.
  • In various aspects, a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the polymerase at connection points on the thumb and finger domains of the polymerase, and wherein such points undergo relative motion in excess of 1 nanometer as the polymerase processes a DNA template.
  • In various aspects, the polymerase in this sensor is engineered to have extended domains which produce a greater range of relative motion as the polymerase processes a DNA template.
  • In various aspects, the polymerase in this sensor is engineered to have additional charge groups that variably influence the internal conduction path as the enzyme processes a DNA template.
  • In various aspects, the polymerase in this circuit is a genetically modified form of E. coli. Pol I, Bst, Taq, Phi29, or T7 DNA polymerases, or a genetically modified reverse transcriptase.
  • In various aspects, a molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the enzyme at connection points in the enzyme comprising at least one of a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner.
  • In various aspects, this circuit further comprises a gate electrode.
  • In various embodiments, a method of sequencing a DNA molecule is disclosed. The method comprises: providing a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes; initiating at least one of a voltage or a current through the circuit; exposing the circuit to a solution containing primed single stranded DNA and/or dNTPs; and measuring electrical signals through the circuit as the polymerase engages and extends a template, wherein the electrical signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
  • In various embodiments, a method of molecular detection is disclosed. The method comprises, providing a circuit further comprising: a positive electrode; a negative electrode spaced apart from the positive electrode; a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes and a gate electrode; initiating at least one of a voltage or a current through the circuit; exposing the circuit to at least one of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode; and measuring an electrical change in the circuit.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The subject matter of the present disclosure is particularly pointed out and distinctly claimed in the concluding portion of the specification. A more complete understanding of the present disclosure, however, may best be obtained by referring to the detailed description and claims when considered in connection with the drawing figures:
  • FIG. 1 illustrates the general concept of a molecular electronic circuit;
  • FIG. 2 illustrates the general concept of engaging an enzyme to a molecular electronic circuit, such as to act as a sensor of enzyme activity with its target;
  • FIG. 3 illustrates an enzyme that is wired directly into the current path, in accordance with various embodiments;
  • FIG. 4 illustrates an enzyme that is wired directly into the current path, with the connection made to an internal alpha-helix structure within the enzyme, in accordance with various embodiments;
  • FIG. 5 illustrates an enzyme that is wired directly into the current path, with the connection made to a series of two or more internal alpha-helix structures in series within the enzyme, in accordance with various embodiments;
  • FIG. 6 illustrates an enzyme that is wired directly into the current path, with the connection made to an internal beta-sheet structure within the enzyme, in accordance with various embodiments;
  • FIG. 7 illustrates an enzyme that is wired directly into the current path, such that connections are made to points of conformational change in the enzyme, to induce tension changes into the circuit during enzyme activity;
  • FIG. 8 illustrates an enzyme that is wired directly into the current path, with additional connections made to stabilize the position of the enzyme;
  • FIG. 9 illustrates a schematic of an enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein the enzyme directly couples to the electrodes without the use of arm molecules;
  • FIG. 10 illustrates a schematic of an enzyme directly wired by two points of contact into a circuit, as well as also having a one-point conjugation to a molecular wire, utilizing one pair of electrodes to measure the combined conduction, in accordance with various embodiments;
  • FIG. 11 illustrates a schematic of an enzyme directly wired by two points of contact into a circuit, as well as also having a one-point conjugation to a molecular wire, utilizing two pairs of electrodes to measure these two modes of conduction independently, in accordance with various embodiments;
  • FIG. 12 illustrates a protein structure view of the E. coli Pol I Klenow Fragment Polymerase enzyme, illustrating the presence of alpha-helix, beta-sheet, and connecting loop structures;
  • FIG. 13 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein a specific alpha-helix is used for the contacts, and molecular arms provide coupling to the electrodes;
  • FIG. 14 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein a specific alpha-helix is used for the contacts, and the polymerase directly couples to the electrodes without the use of arm molecules;
  • FIG. 15 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein arms are wired to the points that undergo relative motion when the finger and thumb domains change relative conformation; and
  • FIG. 16 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, and where additional connecting arms are wired to provide stabilization and fixed spatial orientation.
  • DETAILED DESCRIPTION
  • The detailed description of exemplary embodiments herein makes reference to the accompanying drawings, which show exemplary embodiments by way of illustration and their best mode. While these exemplary embodiments are described in sufficient detail to enable those skilled in the art to practice the inventions detailed herein, it should be understood that other embodiments may be realized and that logical, chemical, and mechanical changes may be made without departing from the spirit and scope of the inventions. Thus, the detailed description herein is presented for purposes of illustration only and not of limitation. For example, unless otherwise noted, the steps recited in any of the method or process descriptions may be executed in any order and are not necessarily limited to the order presented. Furthermore, any reference to singular includes plural embodiments, and any reference to more than one component or step may include a singular embodiment or step. Also, any reference to attached, fixed, connected or the like may include permanent, removable, temporary, partial, full and/or any other possible attachment option. Additionally, any reference to without contact (or similar phrases) may also include reduced contact or minimal contact.
  • In various embodiments of the present disclosure, a molecular circuit is disclosed. The molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes. In various examples, the enzyme comprises a first wiring point connected to the positive electrode and a second wiring point connected to the negative electrode.
  • Definitions and Interpretations
  • As used herein, the term “enzyme” means a molecule that acts to transform another molecule, by engaging with a variety of substrate molecules. Such transformation could include chemical modification, or conformational modification. Common biological enzyme classes are polymerases, ligases, nucleases, kinases, transferases, as well as genetically modified forms of these molecules. Polymerases herein include reverse transcriptases and any genetically modified reverse transcriptase, capable of directly acting on an RNA template. Enzymes are most commonly proteins, but may be composed of multiple amino acid chains, and may also be complexed with other types of molecules, such as RNA in the case of the ribosome enzyme.
  • As used herein, the term “substrate” for an enzyme refers to any of the molecules that the enzyme specifically engages with in the course of performing a transformation. For example, in the specific case of a DNA polymerase, the substrate consists of both a template DNA and dNTPs. In addition to the substrates of the enzyme, the enzyme may also complex with various co-factors that moderate its function or kinetics. For example, in the case of DNA polymerase, divalent cations such as Mg++ are often essential cofactors, but not considered as substrates.
  • As used herein, the term “dNTP” or “dNTPs” refers to any of the deoxynucleotide triphosphates involved in polymerase-based DNA synthesis, or that can be engaged for such DNA synthesis, including both native and modified forms of such molecules.
  • As used herein, the term “buffer” for an enzyme refers to a solution in which the enzyme is viable and functional, and typically containing the substrates and co-factors needed for enzyme activity. Such an enzyme buffer may typically comprise salts, detergents, and surfactants, singly or in various combinations, as well as specific cofactors, such as magnesium or other divalent cations for a polymerase enzyme, along with the substrates, such as DNA and dNTPs for a polymerase enzyme. Such a buffer herein may have its composition modified from standard forms, such as to enhance signal properties in a sensor exposed to the buffer.
  • As used herein, the term “electrode” means any structure that can act as an efficient source or sink of charge carriers. Most commonly these would be metal or semiconductor structures, such as those used in electronic circuits. A pair of spaced apart electrodes herein may comprise a source and drain electrode pair. In various embodiments of the present disclosure, a binding probe-based molecular circuit may further comprise a gate electrode. When present, a gate electrode is used to apply a voltage rather than transfer charge carriers. Thus it supports accumulation of charge carriers to produce a local electric field, but is not intended to pass current. A gate electrode will be electrically isolated from the primary conduction paths of the circuit by some form of insulating layer or material.
  • As used herein, the term “conjugation” means any of the wide variety of means of physically attaching one molecule to another, or to a surface or particle. Such methods typically involve forming covalent or non-covalent chemical bonds, but may also rely on protein-protein interactions, protein-metal interactions, or chemical or physical adsorption via intermolecular (Van der Waals) forces. There is a large variety of such methods know to those skilled in the art of conjugation chemistry. Common conjugation methods relevant to preferred embodiments herein include thiol-metal bonds, maleimide-cysteine bonds, material binding peptides such as gold binding peptides, and click chemistries.
  • As used herein, the term “initiating,” in the context of an electrical parameter, is intended to be broader than the concept of “applying” an electrical value. For example, an electrical current may be initiated in a circuit. Such initiating of a current may be the result of applying a voltage to the circuit, but may be from other actions to the circuit besides applying a voltage. Further, a voltage may be initiated in a circuit. Such initiating of a voltage may be the result of applying a current to the circuit, but may be from other actions to the circuit besides applying an electrical current. In other examples, a voltage or a current may be initiated in one portion of a circuit as the result of applying a voltage or a current to the overall circuit. In a non-limiting example, a flow of electrons initiated from a negative to a positive electrode in a circuit of the present disclosure may be controlled by the voltage applied to the gate electrode of the circuit.
  • In various embodiments of the present disclosure, a molecular sensor comprises an enzyme connected to both a positive and a negative electrode to complete a circuit. Interactions of the enzyme with various substrates are detectable as changes in the current or other electrical parameter measured across the circuit. The present molecular sensor differs from the general concept of a molecular electronic circuit in that the enzyme is directly “wired” to both the positive and negative electrodes rather than bonded to a molecular bridge molecule that spans the gap between the electrodes to complete a circuit.
  • In various aspects of the disclosure, at least one of a voltage or a current is initiated in an enzyme-based molecular circuit. When a target interacts with the enzyme, electrical changes in the circuit are sensed. These electrical changes, or informative electrical signals, may include current, voltage, impedance, conductivity, resistance, capacitance, or the like. In some examples, a voltage is initiated in the circuit and then changes in the current through the circuit are measured as substrates interact with the enzyme. In other examples, a current is initiated in the circuit, and changes to voltage in the circuit are measured as substrates interact with the enzyme. In other examples, impedance, conductivity, or resistance is measured. In examples wherein the circuit further comprises a gate electrode, such as positioned underneath the gap between the positive and negative electrodes, at least one of a voltage or current may be applied to the gate electrode, and voltage, current, impedance, conductivity, resistance, or other electrical change in the circuit may be measured as substrates interact with the enzyme.
  • FIG. 1 illustrates the general concept of a molecular electronic circuit having a bridge molecule 10 attached to and bridging the gap 12 between electrodes 15, as well as some type of conjugation group 20 or other mechanism that binds the molecule to the electrodes (depicted as small shaded squares). FIG. 1 further illustrates that a current, (i), may pass through this molecule and be measured versus time, (t), as shown in the inset plot 25.
  • FIG. 2 illustrates a molecular electronic sensor in which an enzyme 30 is conjugated to the molecular bridge component 31 spanning the electrodes 32, wherein monitoring the current provides a sensor for the enzyme engaging with and processing its target substrate 35 when exposed to a suitable buffer solution. In such a sensor system, the local charge perturbations that result from the target substrate engaging with the enzyme perturb charge transport through the primary bridge component, and are thus registered as a change in conductivity or current versus time, as indicated by the step-up change in the current (i) vs. time (t) current plot inset 38 in FIG. 2.
  • In contrast to the general molecular circuit concept as depicted in FIGS. 1 and 2, in various embodiments of the present disclosure a molecular sensor comprises a single enzyme molecule directly wired into the circuit path, such that all electrical current passing through the molecular circuit must flow through the enzyme. Thus the enzyme is an essential conduction path in the circuit, like an electronic component on a circuit board. The present concept is illustrated generally in FIG. 3, which shows an enzyme 42 connected between molecular arms 40. By forcing all current in the circuit to pass through the enzyme, the current carriers are forced to pass closer to the precise location of electrochemical interactions between the enzyme and target substrate 45, thereby causing such interactions to have greater impact on the current carriers, and, in turn making the overall current more sensitive to the details of these interactions. This is illustrated schematically by the current versus time, (i vs. t), plot inset 50 in FIG. 3, wherein the current step is shown to be much larger than that produced by the configuration of FIG. 2, and also includes additional features not present in a current versus time plot such as depicted in FIG. 2. The higher current step provides improved signaling. Related methods and preferred embodiments herein promote improved signaling of enzyme-based molecular sensors. Further, the configuration of the enzyme as an essential conduction path is fundamentally different from the common configuration of FIG. 2, in which there are many conduction paths that do not pass through the enzyme, and where potentially none of the charge carriers actually traverse the enzyme, and where there is no means provided to direct charge carriers to pass near key active sites within the enzyme.
  • In various embodiments, the enzyme may be coupled to both positive and negative electrodes at two or more points, such as to ensure that charge carriers traversing the molecular structure pass into and out of the enzyme.
  • As shown in the embodiment of FIG. 3, two molecular arms are conjugated to the enzyme to provide physical anchors and entry and exit paths for the current through the enzyme. Such arms may comprise any convenient molecule that provides a conducting connection or semi-conducting connection between the enzyme and the electrodes. Further, molecular arms may provide spanning length extensions, to help span a larger electrode gap 55 that is wider than the 3D structure of the enzyme. Such arms may also provide the advantage of keeping the enzyme away from contacting the electrodes 65 where unfavorable or damaging interactions may occur with the electrodes, such as a denaturing adsorption to the electrode. Such arms may also provide for more compatible or efficient coupling to the electrodes, such as by coupling to the electrodes via chemical groups that are not readily found or made available on the enzyme. For example, in one specific embodiment, the electrode comprises gold and the molecular arm includes a thiol group, such that the arm couples to the gold electrode via well-known thiol-gold binding. Thus the molecular arm accomplishes the binding while the enzyme may not have such available thiol groups. Or, in another embodiment, the arms may present a click-chemistry binding group, for coupling to electrodes that are derivatized with the cognate binding partners for the click chemistry.
  • In various embodiments, molecular arms comprise some form of conjugation 60 to the enzyme, as well as their conjugations or couplings to the electrodes. Many conjugation chemistries can be employed for this purpose. In a non-limiting example, such conjugation comprises chemical crosslinking, which can preferentially couple suitable chemical groups on the arms to amino acid residues on the enzyme. In various embodiments, a maleimide group on the arm couples to a surface cysteine on the enzyme. In other aspects, genetically modified versions of an enzyme may be created and employed, such as enzymes comprising specific amino acids or protein domains engineered into their amino acid structure that provide specific conjugation sites. For example, cysteine amino acids engineered at specific sites on the enzyme provide for the attachment point of arms that present a maleimide group. Two such cysteine sites conjugate to two maleimide derivatized arms to produce a configuration such as that shown in FIG. 3. In this case, one or more native cysteines that would provide competing arm binding sites may be “engineered out” of the amino acid sequence. If not all such sites can be removed, it is possible to use various purification methods from synthetic chemistry to isolate desired enzyme-arm conjugates from unwanted configurations. In other variations, genetic methods are used to engineer into the amino acid sequence of the enzyme amino acids comprising residues that uniquely conjugate to a cognate group on the arms. This variation includes cases where non-standard amino acids are employed, such as amino acids modified to present a click-chemistry group, via protein expression systems that use a modified genetic code and modified transfer RNAs to put non-native amino acids at specific sequence sites in an expressed enzyme protein.
  • In other embodiments, a peptide domain that specifically binds with a cognate group on the arms is engineered into the sequence of a protein enzyme. In one such embodiment, a peptide that is an antigen to an antibody is engineered into the enzyme, and the Fab binding domain of the antibody is used on the arms. One such embodiment is to use the FLAG peptide motif DYKDD, and any suitable ANTI-FLAG Fab domain. Any other peptide antigens and their cognate Fab domains can similarly be used to conjugate arms to specific sites in an engineered enzyme protein, by engineering the peptide antigen into the desired conjugation sites on the enzyme. Other such peptide domains make use of the SPY-TAG/SPY-CATCHER protein-protein binding system, by engineering either the SPY-TAG domain or the SPY-CATCHER domain into the enzyme protein, and placing the cognate domain in the arms. When engineering such peptide binding domains into the enzyme, another embodiment is to add short linker peptide sequences flanking the target peptide, to enhance the availability of the domain for binding. Such short linkers may comprise short glycine and serine rich linkers, as are known to those skilled in the art of protein engineering, including, but not limited to, the linker amino acid sequences G, GS, GSG, GGSG, etc.
  • In various examples, the arm molecules comprise any molecules that provide for conduction of charge carriers into and out of the enzyme. In certain embodiments, such arms comprise molecular wires from the many forms known in field of molecular electronics, functionalized with suitable conjugation and binding groups for wiring to electrodes and enzyme. In various aspects, such arms may comprise single stranded DNA, double stranded DNA, peptides, peptide alpha-helices, antibodies, Fab domains of antibodies, carbon nanotubes, graphene nanoribbons, natural polymers, synthetic polymers, other organic molecules with p-orbitals for electron delocalization, or metal or semiconductor nanorods or nanoparticles. In further embodiments, the arms may comprise double stranded DNA with thiol-bearing groups at one end, and maleimide at the other end that couples to the enzyme, or a peptide alpha-helix with a cysteine or gold binding peptide at one termini, and a maleimide at the other end that couples to the enzyme, or a graphene nanoribbon with thiol-bearing groups at one end, and a maleimide bearing group at the other end that couples to the enzyme. In certain embodiments, the two arm molecules used to couple an enzyme to two electrodes are identical molecules, and in other embodiments, the two arm molecules are different molecules. In some examples, there may be a “positive electrode” arm and a “negative electrode” arm, providing for oriented binding of an enzyme to the corresponding “positive” and “negative” electrodes in FIG. 3.
  • In various embodiments, arm conjugation points connect directly to specific protein structural elements within the enzyme. A non-limiting example is illustrated in FIG. 4, where the arms 75 are shown wired directly to an alpha-helix structure 70 in the enzyme 72. Such structural elements provide preferential conduction paths through the enzyme. Direct wiring to natural conduction paths in the enzyme guide current closer to active regions of interest within the enzyme, such as substrate binding pockets, and may thereby provide for further enhanced current signals, or current signals that carry more information on enzyme-substrate interactions. For example, one embodiment is shown in FIG. 4, where the arms wire directly to an alpha-helix that spans between two points on or near the surface of the enzyme. Another example is shown in FIG. 5, where the arms 80 wire directly to two alpha-helices (the first alpha-helix 85 and the second alpha helix 87) that appear in series internally in the enzyme, with a single connecting loop 90 separating them. Yet another embodiment is shown in FIG. 6, where the arms 95 wire directly to two points 98 on a beta-sheet 100 internal to the enzyme 102.
  • In general, a protein enzyme will have a 3D structure that includes well known secondary structural elements such as alpha-helices and beta-sheets. These are primarily hydrogen bonded structures that can provide discrete conduction paths through the body of the enzyme, to the extent that current carriers, such as electrons, may efficiently hop along such structures, or along the hydrogen bonds that define such structures, with less resistance than otherwise hopping or tunneling off such structures. These structures provide preferential conduction paths that will channel charge carriers, and by selecting such structures, charge is forced to pass close to active regions of the enzyme, and current-based sensing of the activity will be improved. Having the arms directly connected to such structures, or within a small number of amino acids of the termini of such structures, the current flowing along these desirable paths is maximized, and thus the desirable signals that come from the current along such paths is maximized. In this way, current going elsewhere within the enzyme is minimized, and thus the noise from probing these less informative regions is also minimized.
  • In various examples, the wiring can be to such structures that appear in the enzyme “in series”, such as for example, two alpha-helices in series as indicated in FIG. 5, or a beta-sheet in series with an alpha-helix, or three successive alpha-helices. In general, each successive element in series appears in the enzyme primary amino acid sequence as separated from the previous element by a small number of amino acids, such 0, 1, 2, or up to approximately 10 amino acids, which typically form a connecting loop in the secondary structure. Wiring of elements in series may also be achieved by wiring to structures that are not contiguous in the primary amino acid sequence of the enzyme, but are nonetheless spatially contiguous and in conductive contact, and form a preferred conduction path, owing to hydrogen bonding, salt bridges, disulfide bridges, or other types of molecular interaction that establish secondary, tertiary or quaternary protein structure and that can provide a clearly defined and favorable conduction path from one structural element (beta-sheet, alpha-helix) to another. These structural elements of interest for wiring, either in isolation or in series, are most evident when examining the 3D structure of the proteins involved, as can be observed from the crystal structures, and in particular, by examination of the protein structures obtained by X-ray or NMR crystallography. This useful form of structural information is illustrated by the polymerase enzyme structure shown in FIG. 12.
  • In other embodiments, the arms are wired to points on the enzyme that undergo conformation changes or relative motion during enzyme function, such as illustrated in FIG. 7. In this case, the arms 105 are wired to two points 110 that are indicated as having relative motion, as illustrated in the inset 108, during enzyme activity. This configuration can enhance signaling by several means. First, such motions can change the tension in the arms, and it is known that tension changes in molecules can change their conductivity, thus the motion may be transduced via tension into a change in conductivity of the arms, which consequently show up in the current signals. In this way, the current may contain information about the conformational changes in the enzyme. Second, similarly, this configuration can cause tension in the enzyme as it changes conformation, and thus alter conductivity of the enzyme. Since the enzyme is an essential current path, the conformation changes would transduce into current changes, and thereby represent conformation information in the sensing current. This configuration could also enhance signaling by altering the conformational changes of the enzyme, which may in some situations lead to an enhanced signal, for either a native enzyme, or one engineered to specifically benefit from such conformation-sensitive wiring. In one embodiment, an enzyme is engineered to have extended regions that undergo greater conformational change or relative motion (e.g. as demonstrated by extending the length of the two tips of the scissor-shaped enzyme indicated in FIG. 7), so as to enhance the range of motion, and therefore the range of tension changes in the arms and enzymes.
  • In other aspects, conformational changes in the enzyme, such as when induced binding occurs between the enzyme and a substrate, are translated into a twist, torque or rotation of at least one arm, and that twist, torsion or rotation alters the conductivity of the arm. One such example is an arm comprising an organic polymer further comprising polycyclic aromatic rings, such as polythiophene or polyphenylene, whereby previously lined up p-orbitals are rotated out of alignment by C—C bond rotation when the arm is twisted, torqued or rotated in response to an enzyme conformational change. When the arm is twisted, torqued or rotated, the electrons have impeded delocalization through the organic polymer. In certain embodiments, such impeded flow may act on only a subset of the charge carriers, depending on, for example, the polarization or other quantum state of the charge carrier, such as spin polarization of an electron charge carrier, or the momentum or energy state of the charge carrier.
  • Another example is illustrated in FIG. 8, wherein the molecular sensor circuit comprises more than two arms, for example, 3 arms (the first arm 115, the second arm 116, and the third arm 117). The benefits to using additional enzyme wiring points and associated arms include addition of other desirable conduction paths through the enzyme, and increasing the overall conduction through the enzyme. Such additional arms may also provide stabilization, impose a spatial orientation (such as to orient an active site), or otherwise reduce physical degrees of freedom or conformational entropy, which may improve sensing by reducing the variability in conduction that comes from the system having more accessible conformations. Such additional arms may be conductive, but they can also be insulating if they are present primarily to provide stability, orientation, or reduction in spatial degrees of freedom. Such additional arms may connect to the electrode, or to other portions of the structure, such as to a substrate supporting the electrodes. Such arms may connect to additional electrodes in a system comprising more than two electrodes, including the case of a system with a gate electrode, such as a buried gate electrode. Connection to a gate electrode may refer to connection to the conductive portion of the gate, or connection to the insulating layer that separates actual conductive gate from the circuit, or, in the case of a buried gate, the surface layer above the buried gate, such as the connection to the surface illustrated in FIG. 16.
  • As illustrated in FIG. 9, the enzyme may be connected to the electrodes directly 120, as an essential conduction path, without the use of arm molecules. In this case, groups on the enzyme directly couple to the electrodes. Or, in another embodiment, one wiring connection comprises direct coupling to the enzyme, the other via an arm molecule. The advantages of this arm-less configuration include minimizing the length of the conduction path, since the parts of the conduction path outside of the enzyme can be sources of unwanted noise, resistance or capacitance. The considerations above for the case of wiring with arms generally also apply to the special case of an arm-less configuration as well as the configuration of a single arm combined with direct enzyme coupling. Specifically, in embodiments lacking arms, the enzyme may still be wired via internal structures, or at points of conformational change.
  • A sensor comprising a directly wired enzyme as an essential conduction path may have its signal performance enhanced through various environmental factors. For example, the choice of buffer, buffer additives, temperature and applied voltage may be modulated to improve the signal quality. In particular, since enzymes may complex with various cofactors that modulate their kinetics, and the salt levels in the buffer also impact enzyme kinetics, as does temperature, these factors may be used to improve signaling performance. In addition, the overall ionic strength of the buffer solution defines the Debye length in the solution, that is the distance over which electric fields extend in solution, and can impact the extent to which current carriers passing through the enzyme are influenced by the charge distributions of the enzyme and substrate, and thus buffer ionic strength or total salt concentration is another means of influencing or enhancing the signaling. In embodiments utilizing a polymerase enzyme, the divalent cation content of the buffer is known to influence enzyme activity, and the choice of divalent cation, for example from among Mg++, Mn++, Ni++, Zn++, Co++, Ca++, Cr++, and their concentration may be optimized to improve the signaling from a polymerase wired as an essential conduction path.
  • The applied driving voltage may be optimized to improve the signaling from an enzyme wired as an essential conduction path. Based on energy barriers within the enzyme, certain voltages may lead to improved signaling performance. In addition to an applied voltage, various embodiments may also have a gate electrode, such as a buried gate below the lower substrate indicated in FIG. 3, such that voltages applied to the gate electrode further modulate the signaling properties of the enzyme circuit. Certain embodiments may employ voltage spectroscopy, wherein the driving or gate voltages are swept through a range of values, and the signal of interest is in the response from this sweep, which contains information on the interaction between the enzyme and its substrates.
  • In general, the molecular circuit sensors of the present disclosure comprise the wiring of an enzyme with at least two points of electrical contact, so as to make the enzyme an essential conduction path, in contrast to the configuration of FIG. 2. Two-point wiring of the enzyme may be combined with a conjugation 125 to one or more molecular arms 127, as shown in FIGS. 10 and 11. In these embodiments, the current can be both driven through the enzyme, for sensing, and the enzyme can also modulate current through the other molecular wire, as an additional sensing mode. In FIG. 10, these conduction modes are monitored by a single electrode pair 130, and combine to produce a single current, whereas in FIG. 11, these two conduction modes can be monitored by two separate electrode pairs (a first electrode pair 135 and a second electrode pair 140), producing two current measurements 145. In certain embodiments, the sensor may comprise an enzyme 126 wired up with two or more points of contact as a conduction path, in conjunction with additional sensor configuration features. Wiring the enzyme at two points, with input and output electrical contacts, can provide enhanced signaling. Other possible and non-limiting configurations are illustrated in FIGS. 10 and 11.
  • In various embodiments, a molecular circuit sensor comprises a polymerase enzyme. FIG. 12 shows a representative polymerase enzyme 150, the Klenow Fragment of E. coli DNA Polymerase I. FIG. 12 illustrates a ribbon diagram of the enzyme structure, from two different views, with the enzyme engaged with a double-stranded DNA template 170. The enzyme primary structure is a single amino acid sequence of 605 amino acids. The secondary structure and tertiary structure of the enzyme are depicted in FIG. 12. This figure shows the structural elements of the enzyme. In particular, there are 28 distinct alpha-helix elements 160, and two major beta-sheet elements 165, separated by short flexible loop segments 155. Such structural elements are similarly present in other types of polymerases and other enzyme proteins in general. In the course of enzyme activity, these structural features engage in electrical, chemical, mechanical and conformational perturbations, and wiring to these features within an electrical circuit can transduce these perturbations into measured signals.
  • FIG. 13 shows an embodiment where the polymerase 177 is wired as an essential conduction path, and specifically wired to the ends of a long alpha-helix 180 that passes through the center of the enzyme. This alpha-helix was chosen because it passes very near to the active pocket of the polymerase, and therefore can provide for enhanced current sensing of the polymerase activity as it binds to a primed strand and extends the primer through incorporation of dNTPs. Other alpha-helices in the structure will provide other sensing opportunities, and other embodiments comprise wiring to such alpha-helix structures, or the beta-sheet structures, or other such structures occurring in series. The arms 175 indicated in FIG. 13 may comprise double stranded oligonucleotides terminated with a maleimide, which couples to a cysteine genetically engineered into a precise location in a mutant form of the polymerase. In another embodiment, the arms comprise a protein alpha-helix terminated with a maleimide which couples such a cysteine. One specific embodiment of such a mutant polymerase includes cysteine (C) placed at the conjugation points indicated in FIG. 3, which arise from replacing the glutamine (Q) at amino acid position 548 by C, and replacing the serine (S) at amino acid position 508 by C, and these two locations lie just outside and bracket a single long (37 amino acid) alpha-helix that extends from amino acid position 514 to 547. In certain embodiments, the mutant polymerase further has the single native C at amino acid position 584 replaced by a non-cysteine, such as S, so as to provide exactly the two sites for coupling of the maleimide terminated arms, via the well-known maleimide-cysteine conjugation. Making such amino acid substitutions to introduce cysteines should be done in a manner that does not alter highly conserved amino acids (as conserved in comparison to other polymerases), does not alter amino acids in the alpha-helix or other structural elements that are the target of the wiring, does not alter amino acids directly participating in critical enzyme function, such as those that interact directly with the structure of the substrate binding pocket, the DNA substrate or the dNTP substrates. Similar selection principles apply to other enzymes as well when mutating in cysteine as a maleimide conjugation point.
  • FIG. 14 illustrates an alternative embodiment where the mutant polymerase 177 of FIG. 13 is directly conjugated 185 to the electrodes 187, coupling to the internal alpha-helix, without the use of connecting arms. This coupling can be achieved, for example, by utilizing gold electrodes, and a gold-binding peptide (GBP) with a maleimide terminus, such that the maleimide conjugates the GBP to the mutant polymerase at the cysteine sites described above, and the GBP conjugates to the gold electrode, thereby wiring in the polymerase via these two cysteine sites. Other embodiments of direct maleimide-mediated conjugations to the electrodes are enabled by using conjugating groups having the form X-maleimide bonded to the cysteines on the polymerase, such that X is a group that then binds to the electrode surface.
  • FIG. 15 illustrates an alternative embodiment, where the mutant polymerase 177 of FIG. 13 is wired to the electrodes 212 using connecting arms 210 through an alpha-helix 200 adjacent to the binding cleft 205 of the polymerase. The connecting arms are wired to two points 215 on the polymerase. In embodiments, these two points have the ability to move relative to each other, thereby allowing for changes in conductivity and enhanced signaling.
  • FIG. 16 illustrates an embodiment in which multiple arms 190 are used to wire up the polymerase 195 as an essential conducting path, as well as to stabilize its position and orientation relative to the electrodes and substrate. The lower pair of arms indicated can be either conducting or insulating, in accordance with various embodiments.
  • In various embodiments, a circuit comprises an enzyme wired in as an essential conduction path. The circuit may comprise first and second wiring points, connecting to a first and a second electrode such as a positive electrode and a negative electrode.
  • In various embodiments, the circuit may further comprise at least one arm molecule having two ends, one end bonded to the enzyme and the other end bonded to at least one of the electrodes, wherein the at least one arm molecule acts as an electrical wire between the enzyme molecule and at least one of the electrodes. Such an arm molecule may be selected from the group consisting of a double stranded oligonucleotide, a peptide nucleic acid (PNA) duplex, a PNA-DNA hybrid duplex, a protein alpha-helix, a graphene-like nanoribbon, a natural polymer, a synthetic organic molecule e.g. a synthetic polymer, and an antibody Fab domain. In other examples, the enzyme is wired directly to the electrodes without the use of any arm molecules. The wiring may be to an internal structural element in the enzyme, such as an alpha-helix, or a beta sheet, or multiple such elements in series.
  • In various embodiments, a circuit comprises an enzyme wired at points that undergo relative conformational change. In certain aspects, arms comprise molecules that have a tension dependent conductivity. In other examples, arm molecules may have torsion or twist dependent conductivity. Additional wiring points may be used to couple the enzyme at additional sites.
  • In various embodiments, a circuit comprises a polymerase enzyme, such as for example, E. coli Pol I Klenow Fragment, wherein the wiring is to the major alpha-helix extending between amino acids at position 514 and 547. Such connection may rely on the placement of genetically engineered cysteines at or near these amino acid positions. Circuits comprising a polymerase may be used to sense sequence information from a DNA template processed by the polymerase.
  • A circuit in accordance to various embodiments of the present disclosure may be exposed to a solution containing primed single stranded DNA, and/or dNTPs, wherein the current through the circuit is measured as the polymerase engages and extends a template, and the resulting signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
  • The connection between the enzyme molecule and at least one of the positive electrode and negative electrode may comprise any one of: a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner. In certain aspects, the wiring is to points on the thumb and finger domain of the enzyme, where such points undergo relative motion in excess of 1 nm as the polymerase processes a DNA template. In other aspects, the polymerase is engineered to have extended domains that produce a greater range of relative motion as the polymerase processes a DNA template. For example, conformational changes in an enzyme may be accentuated by extending various domains in the enzyme. A polymerase enzyme may also be engineered to have additional charge groups that variably influence the internal conduction path as the enzyme processes a DNA template.
  • In various embodiments, a circuit is exposed to a solution comprising modified dNTPs that variably influence the internal conduction path as the enzyme processes a DNA or RNA template. In some cases, the polymerase enzyme is a genetically modified form of one of: E. coli. Pol I polymerase, Bst polymerase, Taq polymerase, Phi29 polymerase, T7 polymerase, and reverse transcriptase. In other examples, a circuit is exposed to one or more of the conditions of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode.
  • In various embodiments, the polymerase enzyme comprises a reverse transcriptase or genetically modified reverse transcriptase, capable of directly acting on an RNA template. Use of a reverse transcriptase in these circuits has the benefit that the reverse transcriptase can directly process an RNA template, and therefore provide a means for directly sequencing RNA molecules. In various aspects, this reverse transcriptase could be any monomeric reverse transcriptase or a genetically modified form thereof, such as Moloney murine leukemia virus reverse transcriptase, porcine endogenous retrovirus reverse transcriptase, bovine leukemia virus reverse transcriptase, mouse mammary tumor virus reverse transcriptase, or a heterodimeric reverse transcriptase such as human immunodeficiency virus reverse transcriptase or Rous sarcoma virus reverse transcriptase.
  • In certain examples, a method of sequencing a DNA molecule is disclosed. The method comprises: providing an enzyme-based molecular circuit having spaced-apart positive and negative electrodes and a polymerase enzyme molecule connected to both the positive and negative electrodes to form a conductive pathway between the electrodes; initiating at least one of a voltage or a current through the circuit; exposing the circuit to a solution containing primed single stranded DNA and/or dNTPs; and measuring electrical signals through the circuit as the polymerase engages and extends a template, wherein the electrical signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
  • In other aspects, a method of molecular detection is disclosed. The method comprises: (a) providing an enzyme-based molecular circuit having spaced-apart positive and negative electrodes, a polymerase enzyme molecule connected to both the positive and negative electrodes to form a conductive pathway between the electrodes, and a gate electrode; (b) initiating at least one of a voltage or a current through the circuit; (c) exposing the circuit to at least one of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode; and (d) measuring an electrical change in the circuit.
  • Enzyme-based molecular sensors and methods of making and using same are provided. References to “various embodiments”, “one embodiment”, “an embodiment”, “an example embodiment”, etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it is submitted that it is within the knowledge of one skilled in the art to affect such feature, structure, or characteristic in connection with other embodiments whether or not explicitly described. After reading the description, it will be apparent to one skilled in the relevant art(s) how to implement the disclosure in alternative embodiments.
  • Benefits, other advantages, and solutions to problems have been described with regard to specific embodiments. However, the benefits, advantages, solutions to problems, and any elements that may cause any benefit, advantage, or solution to occur or become more pronounced are not to be construed as critical, required, or essential features or elements of the disclosure. The scope of the disclosure is accordingly to be limited by nothing other than the appended claims, in which reference to an element in the singular is not intended to mean “one and only one” unless explicitly so stated, but rather “one or more.” Moreover, where a phrase similar to ‘at least one of A, B, and C’ or ‘at least one of A, B, or C’ is used in the claims or specification, it is intended that the phrase be interpreted to mean that A alone may be present in an embodiment, B alone may be present in an embodiment, C alone may be present in an embodiment, or that any combination of the elements A, B and C may be present in a single embodiment; for example, A and B, A and C, B and C, or A and B and C.
  • All structural, chemical, and functional equivalents to the elements of the above-described various embodiments that are known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the present claims. Moreover, it is not necessary for a device or method to address each and every problem sought to be solved by the present disclosure, for it to be encompassed by the present claims. Furthermore, no element, component, or method step in the present disclosure is intended to be dedicated to the public regardless of whether the element, component, or method step is explicitly recited in the claims. No claim element is intended to invoke 35 U.S.C. 112(f) unless the element is expressly recited using the phrase “means for.” As used herein, the terms “comprises”, “comprising”, or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a molecule, composition, process, method, or device that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such molecules, compositions, processes, methods, or devices.

Claims (1)

We claim:
1. A circuit comprising:
a first electrode;
a second electrode spaced apart from the first electrode;
an enzyme electrically connected to both the first and the second electrodes to form a conductive pathway between the first electrode and the second electrode; and
at least one arm molecule having first and second ends, the first end bonded to the enzyme and the second end bonded to the first electrode, wherein the at least one arm molecule acts as an electrical wire between the enzyme and the first electrode.
US17/586,772 2017-04-25 2022-01-27 Enzymatic circuits for molecular sensors Pending US20220154241A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/586,772 US20220154241A1 (en) 2017-04-25 2022-01-27 Enzymatic circuits for molecular sensors

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762489881P 2017-04-25 2017-04-25
PCT/US2018/029382 WO2018200687A1 (en) 2017-04-25 2018-04-25 Enzymatic circuits for molecular sensors
US16/015,028 US10508296B2 (en) 2017-04-25 2018-06-21 Enzymatic circuits for molecular sensors
US16/684,338 US11268123B2 (en) 2017-04-25 2019-11-14 Enzymatic circuits for molecular sensors
US17/586,772 US20220154241A1 (en) 2017-04-25 2022-01-27 Enzymatic circuits for molecular sensors

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US16/684,338 Continuation US11268123B2 (en) 2017-04-25 2019-11-14 Enzymatic circuits for molecular sensors

Publications (1)

Publication Number Publication Date
US20220154241A1 true US20220154241A1 (en) 2022-05-19

Family

ID=63920073

Family Applications (3)

Application Number Title Priority Date Filing Date
US16/684,338 Active US11268123B2 (en) 2017-04-25 2019-11-14 Enzymatic circuits for molecular sensors
US17/138,314 Pending US20220002777A1 (en) 2017-04-25 2020-12-30 Enzymatic circuits for molecular sensors
US17/586,772 Pending US20220154241A1 (en) 2017-04-25 2022-01-27 Enzymatic circuits for molecular sensors

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US16/684,338 Active US11268123B2 (en) 2017-04-25 2019-11-14 Enzymatic circuits for molecular sensors
US17/138,314 Pending US20220002777A1 (en) 2017-04-25 2020-12-30 Enzymatic circuits for molecular sensors

Country Status (6)

Country Link
US (3) US11268123B2 (en)
EP (1) EP3615685A4 (en)
KR (2) KR102692957B1 (en)
CN (1) CN110546276A (en)
CA (1) CA3057151A1 (en)
WO (1) WO2018200687A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11621345B2 (en) * 2018-08-14 2023-04-04 Pawan Tyagi Systems and methods of fabricating gate electrode on trenched bottom electrode based molecular spintronics device

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3408219B1 (en) 2016-01-28 2022-08-17 Roswell Biotechnologies, Inc Massively parallel dna sequencing apparatus
KR20180105699A (en) 2016-01-28 2018-09-28 로스웰 바이오테크놀로지스 인코포레이티드 Methods and apparatus for measuring analytes using large scale molecular electronic device sensor arrays
EP3882616A1 (en) 2016-02-09 2021-09-22 Roswell Biotechnologies, Inc Electronic label-free dna and genome sequencing
US10597767B2 (en) 2016-02-22 2020-03-24 Roswell Biotechnologies, Inc. Nanoparticle fabrication
US9829456B1 (en) 2016-07-26 2017-11-28 Roswell Biotechnologies, Inc. Method of making a multi-electrode structure usable in molecular sensing devices
WO2018132457A1 (en) 2017-01-10 2018-07-19 Roswell Biotechnologies, Inc. Methods and systems for dna data storage
KR102601324B1 (en) 2017-01-19 2023-11-10 로스웰 바이오테크놀로지스 인코포레이티드 Solid-state sequencing devices containing two-dimensional layer materials
US10508296B2 (en) 2017-04-25 2019-12-17 Roswell Biotechnologies, Inc. Enzymatic circuits for molecular sensors
WO2018200687A1 (en) 2017-04-25 2018-11-01 Roswell Biotechnologies, Inc. Enzymatic circuits for molecular sensors
EP3622086A4 (en) 2017-05-09 2021-04-21 Roswell Biotechnologies, Inc Binding probe circuits for molecular sensors
WO2019046589A1 (en) 2017-08-30 2019-03-07 Roswell Biotechnologies, Inc. Processive enzyme molecular electronic sensors for dna data storage
WO2019075100A1 (en) 2017-10-10 2019-04-18 Roswell Biotechnologies, Inc. Methods, apparatus and systems for amplification-free dna data storage
WO2019217600A1 (en) 2018-05-09 2019-11-14 Stuart Lindsay Method for electronic detection and quantification of antibodies
CN114555832A (en) * 2019-05-27 2022-05-27 通用测序技术公司 Method for identifying components in nucleic acid sequences
SG11202112851RA (en) 2019-06-20 2021-12-30 Univ Arizona State Direct electrical readout of nucleic acid sequences
LU101273B1 (en) * 2019-06-21 2020-12-28 Ecole Polytechnique Fed Lausanne Epfl Sensing platform
KR20220147602A (en) 2020-02-28 2022-11-03 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 How to sequence biopolymers
US20240218415A1 (en) * 2020-03-25 2024-07-04 Universal Sequencing Technology Corporation Enzyme mutants directly attached to a nanogap device
EP4158063A4 (en) * 2020-05-29 2024-05-29 Arizona Board of Regents on behalf of Arizona State University Bioelectronic devices with programmable adaptors
WO2022140573A1 (en) * 2020-12-22 2022-06-30 Recognition AnalytiX, Inc. Devices, methods, and systems for manipulating proteins in bioelectronic circuits

Family Cites Families (286)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0233981Y2 (en) 1986-05-13 1990-09-12
US4923586A (en) 1987-03-31 1990-05-08 Daikin Industries, Ltd. Enzyme electrode unit
US5082627A (en) 1987-05-01 1992-01-21 Biotronic Systems Corporation Three dimensional binding site array for interfering with an electrical field
US5486449A (en) 1989-02-07 1996-01-23 Rohm Co., Ltd. Photomask, photoresist and photolithography for a monolithic IC
GB2244135B (en) 1990-05-04 1994-07-13 Gen Electric Co Plc Sensor devices
US6051380A (en) 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
IL103674A0 (en) 1991-11-19 1993-04-04 Houston Advanced Res Center Method and apparatus for molecule detection
US5414588A (en) 1993-09-20 1995-05-09 The Regents Of The University Of California High performance capacitors using nano-structure multilayer materials fabrication
US5366140A (en) 1993-09-30 1994-11-22 Minnesota Mining And Manufacturing Company Patterned array of uniform metal microbeads
US5965452A (en) 1996-07-09 1999-10-12 Nanogen, Inc. Multiplexed active biologic array
US5871918A (en) 1996-06-20 1999-02-16 The University Of North Carolina At Chapel Hill Electrochemical detection of nucleic acid hybridization
JP3149718B2 (en) 1995-02-03 2001-03-26 松下電器産業株式会社 Single electron transistor
US5583359A (en) 1995-03-03 1996-12-10 Northern Telecom Limited Capacitor structure for an integrated circuit
US6673533B1 (en) 1995-03-10 2004-01-06 Meso Scale Technologies, Llc. Multi-array multi-specific electrochemiluminescence testing
US5639507A (en) 1995-05-03 1997-06-17 Avx Corporation Method of making a planar multi-layer capacitor
ES2223067T3 (en) 1995-12-01 2005-02-16 Innogenetics N.V. IMPEDIMETRIC DETECTION SYSTEM AND PRODUCTION METHOD OF THE SAME.
US6033582A (en) 1996-01-22 2000-03-07 Etex Corporation Surface modification of medical implants
US5881184A (en) 1996-05-22 1999-03-09 Eastman Kodak Company Active pixel sensor with single pixel reset
US6506564B1 (en) 1996-07-29 2003-01-14 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6202471B1 (en) 1997-10-10 2001-03-20 Nanomaterials Research Corporation Low-cost multilaminate sensors
US6110354A (en) 1996-11-01 2000-08-29 University Of Washington Microband electrode arrays
US5767687A (en) 1996-11-29 1998-06-16 Geist; Jon Surface-capacitor type condensable-vapor sensor
US6706473B1 (en) 1996-12-06 2004-03-16 Nanogen, Inc. Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
US7169272B2 (en) 1997-04-30 2007-01-30 Board Of Trustees Of The University Of Arkansas Microfabricated recessed disk microelectrodes: characterization in static and convective solutions
US5982018A (en) 1997-05-23 1999-11-09 Micron Technology, Inc. Thin film capacitor coupons for memory modules and multi-chip modules
FR2764386B1 (en) 1997-06-06 1999-07-16 Commissariat Energie Atomique ELECTRODES HOLDER COMPRISING AT LEAST ONE ELECTRODE COVERED BY A DEPOSIT AND READING SYSTEM THEREOF
JP2000033712A (en) 1997-09-30 2000-02-02 Seiko Epson Corp Method for forming micro-sensor device and method for evaluating liquid function using the same
US6123819A (en) 1997-11-12 2000-09-26 Protiveris, Inc. Nanoelectrode arrays
US6537747B1 (en) 1998-02-03 2003-03-25 Lucent Technologies Inc. Data transmission using DNA oligomers
US6060023A (en) 1998-03-31 2000-05-09 Motorola, Inc. Molecular sensing apparatus
IL124322A (en) 1998-05-04 2002-05-23 Technion Res & Dev Foundation Detection of an entity in a sample
EP1086214B1 (en) 1998-06-10 2009-11-25 Georgia Tech Research Corporation Microneedle devices and methods of their manufacture
IL124903A0 (en) * 1998-06-15 1999-01-26 Bauer Alan Josef An enzyme biosensor
AU6412799A (en) 1998-10-05 2000-04-26 Mosaic Technologies Reverse displacement assay for detection of nucleic acid sequences
US6094335A (en) 1998-10-09 2000-07-25 Advanced Micro Devices, Inc. Vertical parallel plate capacitor
AU2640099A (en) 1999-02-25 2000-09-14 Seiko Epson Corporation Structure member excellent in water-repellency and manufacturing method thereof
US6517669B2 (en) 1999-02-26 2003-02-11 Micron Technology, Inc. Apparatus and method of detecting endpoint of a dielectric etch
EP1196629A2 (en) 1999-04-07 2002-04-17 Dennis Michael Connolly High resolution dna detection methods and devices
DE19916921A1 (en) 1999-04-14 2000-10-19 Fraunhofer Ges Forschung Electrical sensor array
US7122152B2 (en) 1999-05-10 2006-10-17 University Of Florida Spatiotemporal and geometric optimization of sensor arrays for detecting analytes fluids
AU7952700A (en) 1999-10-20 2001-04-30 Takatoshi Miyahara Gene detecting chip, detector, and detecting method
DE19960076C2 (en) 1999-12-13 2002-12-05 November Ag Molekulare Medizin Method and device for the detection and quantification of biomolecules
US20020090649A1 (en) 1999-12-15 2002-07-11 Tony Chan High density column and row addressable electrode arrays
DE10015818A1 (en) 2000-03-30 2001-10-18 Infineon Technologies Ag Biosensor and method for determining macromolecular biopolymers using a biosensor
AU2001252973A1 (en) 2000-04-17 2001-10-30 Purdue Research Foundation Biosensor and related method
AU6114501A (en) 2000-05-03 2001-11-12 Jen Gau Jr Biological identification system with integrated sensor chip
FR2811316B1 (en) 2000-07-06 2003-01-10 Saint Gobain TRANSPARENT TEXTURE SUBSTRATE AND METHODS OF OBTAINING SAME
US6670131B2 (en) 2000-11-30 2003-12-30 Kabushiki Kaisha Toshiba Nucleic acid detection method and apparatus, and vessel for detecting nucleic acid
NL1016779C2 (en) 2000-12-02 2002-06-04 Cornelis Johannes Maria V Rijn Mold, method for manufacturing precision products with the aid of a mold, as well as precision products, in particular microsieves and membrane filters, manufactured with such a mold.
DE10063739B4 (en) 2000-12-21 2009-04-02 Ferro Gmbh Substrates with self-cleaning surface, process for their preparation and their use
WO2002079514A1 (en) 2001-01-10 2002-10-10 The Trustees Of Boston College Dna-bridged carbon nanotube arrays
US6749731B2 (en) 2001-01-31 2004-06-15 Kyocera Corporation Gene detection chip and detection device
KR100878281B1 (en) 2001-03-14 2009-01-12 유니버시티 오브 매사츄세츠 Nanofabrication
DE10113550A1 (en) 2001-03-20 2002-10-02 Infineon Technologies Ag Method for detecting macromolecular biopolymers using an electrode arrangement
US20040048241A1 (en) 2001-06-11 2004-03-11 Freeman Beverly Annette Methods for attaching molecules
US20040023253A1 (en) 2001-06-11 2004-02-05 Sandeep Kunwar Device structure for closely spaced electrodes
WO2003042396A2 (en) 2001-06-11 2003-05-22 Genorx, Inc. Electronic detection of biological molecules using thin layers
US6824974B2 (en) 2001-06-11 2004-11-30 Genorx, Inc. Electronic detection of biological molecules using thin layers
US7297494B2 (en) 2001-06-25 2007-11-20 Georgia Tech Research Corporation Activatable probes and methods for in vivo gene detection
WO2003006103A2 (en) 2001-07-12 2003-01-23 Merck & Co., Inc. Electrical field stimulation of eukaryotic cells
US6483125B1 (en) 2001-07-13 2002-11-19 North Carolina State University Single electron transistors in which the thickness of an insulating layer defines spacing between electrodes
US20030040000A1 (en) 2001-08-08 2003-02-27 Connolly Dennis M. Methods for attaching nucleic acid molecules to electrically conductive surfaces
WO2003020946A2 (en) 2001-08-14 2003-03-13 The Penn State Research Foundation Fabrication of molecular scale devices using fluidic assembly
US6861224B2 (en) 2001-11-02 2005-03-01 Fujitsu Limited Protein detecting device
US20030109031A1 (en) 2001-11-06 2003-06-12 Chafin David R. System for detecting biological materials in a sample
US6905586B2 (en) 2002-01-28 2005-06-14 Ut-Battelle, Llc DNA and RNA sequencing by nanoscale reading through programmable electrophoresis and nanoelectrode-gated tunneling and dielectric detection
US6743368B2 (en) 2002-01-31 2004-06-01 Hewlett-Packard Development Company, L.P. Nano-size imprinting stamp using spacer technique
AU2003243165A1 (en) 2002-04-26 2003-11-10 The Penn State Research Foundation Integrated nanomechanical sensor array chips
US20040014106A1 (en) 2002-05-14 2004-01-22 Nanosphere, Inc. Electrical detection of DNA hybridization and specific binding events
US20030224387A1 (en) 2002-05-22 2003-12-04 Sandeep Kunwar Association of molecules with electrodes of an array of electrodes
EP1516377A2 (en) 2002-06-05 2005-03-23 Reveo, Inc. Layered electrochemical cell and manufacturing method therefor
EP1376111A1 (en) 2002-06-24 2004-01-02 Universite Catholique De Louvain Method and device for high sensitivity detection of the presence of DNA and other probes
JP4196947B2 (en) 2002-07-02 2008-12-17 パナソニック株式会社 Biosensor, biosensor chip and biosensor device
US6755423B2 (en) 2002-07-17 2004-06-29 Li Jiun Chiu Tool coupling device for changeable tool members
US7470533B2 (en) 2002-12-20 2008-12-30 Acea Biosciences Impedance based devices and methods for use in assays
DE10242560A1 (en) 2002-09-13 2004-03-25 Creavis Gesellschaft Für Technologie Und Innovation Mbh Process for preparation of self-cleaning surfaces on coated flat textile structures useful for cladding technical textiles and structures obtained from these and production of raincoats and safety clothing with signaling effect
US20040063100A1 (en) 2002-09-30 2004-04-01 Wang Chung Lin Nanoneedle chips and the production thereof
DE10247679A1 (en) 2002-10-12 2004-04-22 Fujitsu Ltd., Kawasaki Semiconductor body structure, as a biosensor, has two thick layers of one material separated by a thin different intermediate layer forming a nano gap, with organic wire structures as the contacts
US7183055B2 (en) 2002-11-01 2007-02-27 Wisconsin Alumni Research Foundation Direct radio-frequency detection of nucleotide hybridization at microelectrodes
WO2004065570A2 (en) 2003-01-23 2004-08-05 Integrated Nano-Technologies, Llc Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces
CA2516820A1 (en) 2003-02-07 2004-11-18 Wisconsin Alumni Research Foundation Nanocylinder-modified surfaces
US20050164371A1 (en) 2003-03-28 2005-07-28 Fujitsu Limited Cavity electrode structure, and sensor and protein detection device using the same
US7172917B2 (en) 2003-04-17 2007-02-06 Robert Bosch Gmbh Method of making a nanogap for variable capacitive elements, and device having a nanogap
JP4871726B2 (en) 2003-04-28 2012-02-08 ナノシス・インク. Super lyophobic surface, its preparation and use
WO2004096986A2 (en) 2003-04-29 2004-11-11 Integrated Nano-Technologies, Llc Method for quantitative detection of nucleic acid molecules
JP2004347532A (en) 2003-05-23 2004-12-09 Japan Science & Technology Agency Biosensor
US20050156157A1 (en) 2003-07-21 2005-07-21 Parsons Gregory N. Hierarchical assembly of interconnects for molecular electronics
JP4059181B2 (en) 2003-09-29 2008-03-12 株式会社村田製作所 Manufacturing method of multi-terminal type multilayer ceramic electronic components
JP2005109269A (en) 2003-09-30 2005-04-21 Hitachi Ltd Semiconductor radiation detector and semiconductor radiation imager
US7132298B2 (en) 2003-10-07 2006-11-07 Hewlett-Packard Development Company, L.P. Fabrication of nano-object array
WO2005081707A2 (en) 2003-11-20 2005-09-09 Biowarn, Llc Methodology and apparatus for the detection of biological substances
WO2005108612A2 (en) 2003-11-28 2005-11-17 Genorx, Inc. Nanoscale biosensor device, system and technique
ATE458194T1 (en) 2003-12-16 2010-03-15 Dynabyte Informationssysteme G CONNECTOR MODULE FOR BLOOD ANALYSIS
DE10359173B4 (en) 2003-12-17 2006-11-09 Robert Bosch Gmbh Measuring device with a plurality of potentiometric electrode pairs arranged on a substrate
US7451381B2 (en) 2004-02-03 2008-11-11 Phonex Broadband Corporation Reliable method and system for efficiently transporting dynamic data across a network
US20050247573A1 (en) 2004-03-23 2005-11-10 Hideaki Nakamura Biosensors
US8354066B2 (en) 2004-03-24 2013-01-15 Technion Research & Development Foundation Ltd. Artificial receptors
US20050221473A1 (en) 2004-03-30 2005-10-06 Intel Corporation Sensor array integrated circuits
US8138496B2 (en) 2004-04-01 2012-03-20 Nanyang Technological University Addressable transistor chip for conducting assays
US20060019273A1 (en) 2004-05-12 2006-01-26 Connolly Dennis M Detection card for analyzing a sample for a target nucleic acid molecule, and uses thereof
US7385295B2 (en) 2004-06-24 2008-06-10 California Institute Of Technology Fabrication of nano-gap electrode arrays by the construction and selective chemical etching of nano-crosswire stacks
US7265019B2 (en) 2004-06-30 2007-09-04 International Business Machines Corporation Elastomeric CMOS based micro electromechanical varactor
US7150904B2 (en) 2004-07-27 2006-12-19 Ut-Battelle, Llc Composite, ordered material having sharp surface features
US7258731B2 (en) 2004-07-27 2007-08-21 Ut Battelle, Llc Composite, nanostructured, super-hydrophobic material
US7655275B2 (en) 2004-08-02 2010-02-02 Hewlett-Packard Delopment Company, L.P. Methods of controlling flow
US20060029808A1 (en) 2004-08-06 2006-02-09 Lei Zhai Superhydrophobic coatings
EP1630882B1 (en) 2004-08-31 2012-05-02 STMicroelectronics S.r.l. Nanometric structure and corresponding manufacturing method
DE602004016496D1 (en) 2004-08-31 2008-10-23 St Microelectronics Srl Process for the preparation of a host structure for nanometer-sized elements
DE102004042729B4 (en) 2004-09-03 2018-02-01 Robert Bosch Gmbh Bio-chip with an electrode array on a substrate
US20070048748A1 (en) 2004-09-24 2007-03-01 Li-Cor, Inc. Mutant polymerases for sequencing and genotyping
US7507320B2 (en) 2004-10-09 2009-03-24 Academia Sinica Single-atom tip and preparation method thereof
EP1810015A1 (en) 2004-10-14 2007-07-25 Kabushiki Kaisha Toshiba Fet-based nucleic acid detecting sensor
US7541004B2 (en) 2004-11-12 2009-06-02 Predict, Inc. MEMS-based sensor for lubricant analysis
US7785785B2 (en) 2004-11-12 2010-08-31 The Board Of Trustees Of The Leland Stanford Junior University Charge perturbation detection system for DNA and other molecules
DE102004060738B4 (en) 2004-12-15 2008-07-03 Forschungszentrum Jülich GmbH Process for the structured application of molecules to a conductor track
EP1848990A1 (en) 2005-02-18 2007-10-31 Midorion Ab Sensor for detection of single molecules
US9695472B2 (en) 2005-03-04 2017-07-04 Intel Corporation Sensor arrays and nucleic acid sequencing applications
WO2006102292A2 (en) 2005-03-21 2006-09-28 The Trustees Of The University Of Pennsylvania Nanogaps: methods and devices containing same
US20090062684A1 (en) 2005-03-31 2009-03-05 Globalreach Holding Aps Apparatus and method for a global model of hollow internal organs including the determination of cross-sectional areas and volume in internal hollow organs and wall properties
WO2006132694A2 (en) 2005-04-01 2006-12-14 Clemson University Ultrahydrophobic substrates
US7579184B2 (en) 2005-06-02 2009-08-25 Board Of Trustees Of Michigan State University Methods to increase dynamic range and improve quantitative analysis in rapid biosensors
US7417418B1 (en) 2005-06-14 2008-08-26 Ayliffe Harold E Thin film sensor
WO2007053242A2 (en) 2005-09-19 2007-05-10 Wayne State University Transparent hydrophobic article having self-cleaning and liquid repellant features and method of fabricating same
FR2893266B1 (en) 2005-11-14 2007-12-21 Commissariat Energie Atomique SUPERHYDROPHIL OR SUPERHYDROPHOBIC PRODUCT, PROCESS FOR PRODUCING THE SAME AND USE THEREOF
KR100757389B1 (en) 2005-12-06 2007-09-11 한국전자통신연구원 Sensors having nano-gap electrode and their manufacturing method
EP1977444A4 (en) 2005-12-15 2009-05-13 Univ Columbia Sensing devices from molecular electronic devices
US8706219B2 (en) 2005-12-22 2014-04-22 Board Of Regents, The University Of Texas System Method and apparatus for monitoring an organ of a patient
US7649198B2 (en) 2005-12-28 2010-01-19 Industrial Technology Research Institute Nano-array and fabrication method thereof
WO2007087377A2 (en) 2006-01-25 2007-08-02 Massachusetts Institute Of Technology Photoelectrochemical synthesis of high density combinatorial polymer arrays
WO2007102960A2 (en) 2006-01-30 2007-09-13 Ashland Licensing And Intellectual Property Llc Hydrophobic self-cleaning coating compositions
US20070184247A1 (en) 2006-02-03 2007-08-09 Simpson John T Transparent, super-hydrophobic, disordered composite material
US7357018B2 (en) 2006-02-10 2008-04-15 Agilent Technologies, Inc. Method for performing a measurement inside a specimen using an insertable nanoscale FET probe
EP2002248A1 (en) 2006-03-17 2008-12-17 Element Six Limited Microelectrode array
US20090011222A1 (en) 2006-03-27 2009-01-08 Georgia Tech Research Corporation Superhydrophobic surface and method for forming same
US20070227300A1 (en) 2006-03-31 2007-10-04 Quantumsphere, Inc. Compositions of nanometal particles containing a metal or alloy and platinum particles for use in fuel cells
US20070231542A1 (en) 2006-04-03 2007-10-04 General Electric Company Articles having low wettability and high light transmission
GB2437328A (en) 2006-04-10 2007-10-24 Cambridge Display Tech Ltd Electric devices and methods of manufacture
GB0607205D0 (en) 2006-04-10 2006-05-17 Diagnoswiss Sa Miniaturised biosensor with optimized anperimetric detection
US20090162927A1 (en) 2006-05-31 2009-06-25 Yeda Research And Development Company Ltd. Nanotubes and nanowires based electronic devices and method of fabrication thereof
JP2008026109A (en) 2006-07-20 2008-02-07 Fujifilm Corp Fine structure, its manufacturing method, sensor device and raman spectroscopic device
US8394590B2 (en) 2006-08-02 2013-03-12 California Institute Of Technology Capture agents and related methods and systems for detecting and/or sorting targets
WO2008020813A1 (en) 2006-08-16 2008-02-21 Agency For Science, Technology And Research Method of electrically detecting a biological analyte molecule
ITTO20060774A1 (en) 2006-10-27 2008-04-28 St Microelectronics Srl MICROELETTROMECHANICAL SENSOR WITH MULTIPLE SCALES VALUES AND SENSITIVITY
JP4986138B2 (en) 2006-11-15 2012-07-25 独立行政法人産業技術総合研究所 Method for manufacturing mold for optical element having antireflection structure
EP2653861B1 (en) 2006-12-14 2014-08-13 Life Technologies Corporation Method for sequencing a nucleic acid using large-scale FET arrays
GB0625070D0 (en) 2006-12-15 2007-01-24 Imp Innovations Ltd Characterization of molecules
JP2008258594A (en) 2007-03-09 2008-10-23 Hokkaido Univ Method of manufacturing carbon nanotube field-effect transistor, and biosensor device
KR100854486B1 (en) 2007-04-05 2008-08-26 한국기계연구원 Manufacturing method for super water-repellent surface
US9139614B2 (en) 2007-04-25 2015-09-22 The United States Of America, As Represented By The Secretary Of The Navy Modular linkers for conjugation of organic substances to substantially inorganic substances and methods of manufacture and use thereof
AT505495A1 (en) 2007-07-04 2009-01-15 Arc Austrian Res Centers Gmbh METHOD FOR IDENTIFYING AND QUANTIFYING ORGANIC AND BIOCHEMICAL SUBSTANCES
US8278188B2 (en) 2007-07-19 2012-10-02 University of Pittsburgh—of the Commonwealth System of Higher Education Manipulation, detection, and assay of small scale biological particles
EP2195648B1 (en) 2007-09-12 2019-05-08 President and Fellows of Harvard College High-resolution molecular graphene sensor comprising an aperture in the graphene layer
US20100285601A1 (en) 2007-09-28 2010-11-11 Agency For Science, Technology And Research Method of electrically detecting a nucleic acid molecule
WO2009070796A1 (en) 2007-11-29 2009-06-04 President And Fellows Of Harvard College Assembly and deposition of materials using a superhydrophobic surface structure
WO2009082706A1 (en) 2007-12-21 2009-07-02 The Trustees Of Columbia University In The City Of New York Active cmos sensor array for electrochemical biomolecular detection
US8372585B2 (en) 2007-12-31 2013-02-12 Intel Corporation Electronic sensing for nucleic acid sequencing
US8304273B2 (en) 2008-01-24 2012-11-06 Massachusetts Institute Of Technology Insulated nanogap devices and methods of use thereof
US8183648B2 (en) 2008-01-25 2012-05-22 Ut-Battelle, Llc Nanoscopic electrode molecular probes
CN101231287B (en) 2008-02-22 2011-09-14 东南大学 Method for preparing biosensor by arraying nanometer particles in external field evoked electrode
US20090297913A1 (en) 2008-03-25 2009-12-03 The University Of Georgia Research Foundation, Inc. Nanostructure-Enhanced stereo-electrodes for fuel cells and biosensors
US8753893B2 (en) 2008-06-19 2014-06-17 Ben H. Liu Multi-dimensional fluid sensors and related detectors and methods
US7970332B2 (en) 2008-06-30 2011-06-28 Xerox Corporation Oil less fusing using nano/micro textured fusing surfaces
WO2010044932A2 (en) 2008-07-11 2010-04-22 Cornell University Nanofluidic channels with integrated charge sensors and methods based thereon
WO2010019887A1 (en) 2008-08-14 2010-02-18 Brookhaven Science Associates Structured pillar electrodes
WO2010022107A2 (en) 2008-08-18 2010-02-25 The Regents Of The University Of California Nanostructured superhydrophobic, superoleophobic and/or superomniphobic coatings, methods for fabrication, and applications thereof
US20100044212A1 (en) 2008-08-21 2010-02-25 Snu R&Db Foundation Vertically standing ionic polymer-metal composite
ES2636664T3 (en) 2008-09-02 2017-10-06 The Governing Council Of The University Of Toronto Nanostructured microelectrodes and biodetection devices that incorporate them
US20100132771A1 (en) 2008-10-06 2010-06-03 The Regents Of The University Of California 3D Carbon Nanotubes Membrane as a Solar Energy Absorbing Layer
EP2350644B1 (en) 2008-11-18 2015-01-07 THE UNITED STATES OF AMERICA as represented by the Secretary, Department of Health and Human Services A semiconductor for measuring biological interactions
US8563240B2 (en) 2008-12-31 2013-10-22 Intel Corporation Nucleic acid sequencing and electronic detection
US8283936B2 (en) 2009-02-09 2012-10-09 Board Of Regents, The University Of Texas System Nano-scale biosensors
US20100206367A1 (en) 2009-02-18 2010-08-19 Korea Institute Of Industrial Technology Method for fabricating silicon nano wire, solar cell including silicon nano wire and method for fabricating solar cell
US8106428B2 (en) 2009-03-03 2012-01-31 Board Of Regents, The University Of Texas System Nano-scale bridge biosensors
WO2010104479A1 (en) 2009-03-11 2010-09-16 Agency For Science, Technology And Research Electrical sensor for ultrasensitive nucleic acid detection
US20100288543A1 (en) 2009-04-14 2010-11-18 Nanoink, Inc. Conducting lines, nanoparticles, inks, and patterning
US20110291673A1 (en) 2009-04-27 2011-12-01 Sharp Kabushiki Kaisha Chemical sensor
US20100285272A1 (en) 2009-05-06 2010-11-11 Shari Elizabeth Koval Multi-length scale textured glass substrates for anti-fingerprinting
US8313633B2 (en) 2009-07-28 2012-11-20 Polestar Technologies, Inc. Molecular imprinted nanosensors and process for producing same
US8911972B2 (en) * 2009-12-16 2014-12-16 Pacific Biosciences Of California, Inc. Sequencing methods using enzyme conformation
EP2366994A1 (en) 2010-03-18 2011-09-21 Wolfgang Knoll Biosensor on thin-film transistors
US8940663B2 (en) 2010-04-07 2015-01-27 Board Of Regents, The University Of Texas System Nano-scale biosensors
US20110311853A1 (en) 2010-06-17 2011-12-22 Lsi Corporation Electrochemical cell system and apparatus to provide energy to a portable electronic device
WO2011159942A1 (en) 2010-06-18 2011-12-22 Illumina, Inc. Conformational probes and methods for sequencing nucleic acids
KR101136534B1 (en) 2010-09-07 2012-04-17 한국기계연구원 Probe card and manufacturing method thereof
US9231133B2 (en) 2010-09-10 2016-01-05 International Business Machines Corporation Nanowires formed by employing solder nanodots
US9070492B2 (en) 2010-09-14 2015-06-30 The General Hospital Corporation Nanoporous metal multiple electrode array and method of making same
US9187783B2 (en) 2010-10-04 2015-11-17 Genapsys, Inc. Systems and methods for automated reusable parallel biological reactions
WO2012054904A2 (en) 2010-10-21 2012-04-26 The Regents Of The University Of California Microfluidics with wirelessly powered electronic circuits
GB2485559A (en) 2010-11-18 2012-05-23 Univ Plymouth Graphene based electronic device
US20120258881A1 (en) 2010-11-22 2012-10-11 The University Of Chicago Methods and/or Use of Oligonucleotide Conjugates for Assays and Microscopy/Imaging Detections
ES2641871T3 (en) 2010-12-17 2017-11-14 The Trustees Of Columbia University In The City Of New York DNA sequencing by synthesis using modified nucleotides and nanopore detection
US9956743B2 (en) 2010-12-20 2018-05-01 The Regents Of The University Of California Superhydrophobic and superoleophobic nanosurfaces
RU2564923C2 (en) 2010-12-31 2015-10-10 Цилаг Гмбх Интернэшнл Systems and methods for high-accuracy analyte measurement
US9608101B2 (en) 2011-01-04 2017-03-28 Ecole Polytechnique Federale De Lausanne (Epfl) Semiconductor device
TW201231948A (en) 2011-01-26 2012-08-01 zhi-yu Zhao Method for forming frozen biological test strip for electron microscope and device thereof
US8652768B1 (en) 2011-01-31 2014-02-18 Sandia Corporation Nanopatterns by phase separation of patterned mixed polymer monolayers
EP2492673A1 (en) 2011-02-28 2012-08-29 Lexogen GmbH Biosensor array formed by junctions of functionalized electrodes
EP2492674A1 (en) 2011-02-28 2012-08-29 Lexogen GmbH Biosensor array formed by junctions of functionalized electrodes
US20140054788A1 (en) 2011-03-08 2014-02-27 Japan Science And Technology Agency Method for fabricating nanogap electrodes, nanogap electrodes array, and nanodevice with the same
US20140045190A1 (en) 2011-04-19 2014-02-13 The Hong Kong University Of Science And Technology Method and device for monitoring real-time polymerase chain reaction (pcr) utilizing electro-active hydrolysis probe (e-tag probe)
WO2012146377A1 (en) 2011-04-27 2012-11-01 Dmitry Cherkasov Method and components for detecting nucleic acid chains
KR101548771B1 (en) 2011-06-23 2015-09-01 삼성전기주식회사 Chip type laminated capacitor
KR102023754B1 (en) 2011-07-27 2019-09-20 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 Nanopore sensors for biomolecular characterization
KR20140050046A (en) 2011-08-04 2014-04-28 닛산 가가쿠 고교 가부시키 가이샤 Resist underlayer film-forming composition for euv lithography containing condensation polymer
US8685858B2 (en) 2011-08-30 2014-04-01 International Business Machines Corporation Formation of metal nanospheres and microspheres
WO2013095730A2 (en) 2011-09-19 2013-06-27 University Of Utah Research Foundation Multimode platform for detection of compounds
US9347900B2 (en) 2011-10-14 2016-05-24 Pacific Biosciences Of California, Inc. Real-time redox sequencing
US20130108956A1 (en) 2011-11-01 2013-05-02 Az Electronic Materials Usa Corp. Nanocomposite positive photosensitive composition and use thereof
EP2788480B1 (en) * 2011-12-08 2019-01-16 Roche Diagnostics GmbH Dna polymerases with improved activity
GB2511230B (en) 2011-12-15 2018-03-14 Intel Corp Diamond electrode nanogap transducers
EP4108782B1 (en) 2011-12-22 2023-06-07 President and Fellows of Harvard College Compositions and methods for analyte detection
US20130183492A1 (en) 2012-01-17 2013-07-18 Snu R&Db Foundation Metal nanoparticles on substrate and method of forming the same
US20130214875A1 (en) 2012-02-16 2013-08-22 Elwha Llc Graphene sheet and nanomechanical resonator
US20130239349A1 (en) 2012-03-14 2013-09-19 Palo Alto Research Center Incorporated Self-powered manual toothbrush with sensors
UA116205C2 (en) 2012-04-09 2018-02-26 Енвіролоджикс Інк. Compositions and methods for quantifying a nucleic acid sequence in a sample
US9393590B2 (en) 2012-04-16 2016-07-19 Temple University—Of the Commonwealth System of Higher Education Self-assembly of small structures
WO2013165588A1 (en) 2012-05-01 2013-11-07 Life Technologies Corporation Methods for analysis of dna fragments
CN102706940B (en) 2012-06-15 2014-05-14 湖南大学 Electrochemical sensor capable of detecting trace mercury in water body, and preparation method and application thereof
US9551682B2 (en) 2012-06-29 2017-01-24 Intel Corporation High throughput biochemical detection using single molecule fingerprinting arrays
EP2875128B8 (en) 2012-07-19 2020-06-24 Oxford Nanopore Technologies Limited Modified helicases
US8741688B2 (en) 2012-07-24 2014-06-03 Micron Technology, Inc. Methods of forming a metal chalcogenide material
US9070733B2 (en) 2012-07-25 2015-06-30 California Institute Of Technology Nanopillar field-effect and junction transistors with functionalized gate and base electrodes
JP2015528282A (en) 2012-08-06 2015-09-28 クワンタムディーエックス・グループ・リミテッド Methods and kits for nucleic acid sequencing
TWI492384B (en) 2012-08-17 2015-07-11 Univ Nat Chiao Tung Protein transistor devic
TWI514566B (en) 2012-09-19 2015-12-21 Univ Nat Chiao Tung Semiconductor bio-nanowire device and method for fabricating the same
ES2750635T3 (en) 2012-10-16 2020-03-26 Abbott Lab Method of increasing the length of Debye on the surface of a sensor in a sample solution and the corresponding computer-readable storage medium
WO2014066770A1 (en) 2012-10-26 2014-05-01 Research Triangle Institute, International Intermediate band semiconductors, heterojunctions, and optoelectronic devices utilizing solution processed quantum dots, and related methods
US20150293025A1 (en) 2012-12-18 2015-10-15 Toray Industries Inc. Metal dot substrate and method of manufacturing metal dot substrate
US20140218637A1 (en) 2013-02-06 2014-08-07 Nanchang O-Film Tech. Co., Ltd. Conductive film, manufacturing method thereof, and touch screen including the conducting film
CN103187119B (en) 2013-02-06 2014-08-06 南昌欧菲光科技有限公司 Conductive film, preparation method for conductive film and touch screen comprising conductive film
US9040363B2 (en) 2013-03-20 2015-05-26 International Business Machines Corporation FinFET with reduced capacitance
FR3003751A1 (en) 2013-03-27 2014-10-03 Jacques Geloen SATURATION VISUALIZATION DEVICE FOR PROTECTION OF UROFECAL INCONTINENCE.
US9915614B2 (en) 2013-04-26 2018-03-13 Academia Sinica Microfluidic systems and devices for molecular capture, manipulation, and analysis
EP2994544B1 (en) 2013-05-06 2019-10-02 Pacific Biosciences Of California, Inc. Real-time electronic sequencing
US8901621B1 (en) 2013-06-18 2014-12-02 International Business Machines Corporation Nanochannel process and structure for bio-detection
US9182369B2 (en) 2013-06-19 2015-11-10 Globalfoundries Inc. Manufacturable sub-3 nanometer palladium gap devices for fixed electrode tunneling recognition
TW201502276A (en) * 2013-07-09 2015-01-16 Univ Nat Chiao Tung Sequencing method for label-free single molecular nucleic acid
DE102013012145A1 (en) * 2013-07-20 2015-01-22 Borros Arneth Protein transistor based on anti-silicon antibody
US20150049332A1 (en) 2013-07-30 2015-02-19 The Curators Of The University Of Missouri Gold nanoisland arrays
CN106104274B (en) 2013-09-18 2018-05-22 量子生物有限公司 biomolecule sequencing device, system and method
US9236841B2 (en) 2013-09-19 2016-01-12 Analog Devices, Inc. Current-feedback operational amplifier
WO2015102746A2 (en) 2013-11-04 2015-07-09 Massachusetts Institute Of Technology Electronics including graphene-based hybrid structures
CN105980580B (en) 2013-11-17 2020-03-03 宽腾矽公司 Optical system and assay chip for detecting, detecting and analyzing molecules
US10746683B2 (en) 2013-12-12 2020-08-18 Altratech Limited Capacitive sensor and method of use
US9472396B2 (en) 2014-04-15 2016-10-18 University Of Central Florida Research Foundation, Inc. Plasma treated semiconductor dichalcogenide materials and devices therefrom
TW201602355A (en) 2014-04-28 2016-01-16 量子生物系統公司 Nanogap electrode devices and systems and methods for forming the same
EP2947779A1 (en) 2014-05-23 2015-11-25 Thomson Licensing Method and apparatus for storing information units in nucleic acid molecules and nucleic acid storage system
SG11201609692SA (en) 2014-06-03 2016-12-29 Illumina Inc Compositions, systems, and methods for detecting events using tethers anchored to or adjacent to nanopores
AU2015269053A1 (en) 2014-06-06 2016-12-22 Solstice Biologics, Ltd. Polynucleotide constructs having bioreversible and non-bioreversible groups
DK3460075T3 (en) 2014-07-15 2021-02-01 Illumina Inc Biochemically activated electronic device
GB2528682A (en) 2014-07-28 2016-02-03 Isis Innovation Plasmonic filter
JP6443699B2 (en) 2014-08-29 2018-12-26 国立研究開発法人科学技術振興機構 Nanodevice
US9859513B2 (en) 2014-11-25 2018-01-02 University Of Kentucky Research Foundation Integrated multi-terminal devices consisting of carbon nanotube, few-layer graphene nanogaps and few-layer graphene nanoribbons having crystallographically controlled interfaces
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
CA2971268A1 (en) * 2014-12-18 2016-06-23 The Regents Of The University Of California Detection of nucleic acid polymerase conformational changes using a nanotube
US20160187282A1 (en) 2014-12-26 2016-06-30 Intel Corporation Device for single molecule detection and fabrication methods thereof
US9306164B1 (en) 2015-01-30 2016-04-05 International Business Machines Corporation Electrode pair fabrication using directed self assembly of diblock copolymers
WO2016157117A1 (en) 2015-03-31 2016-10-06 Rg Smart Pte. Ltd. Nanoelectronic sensor pixel
FR3035220A1 (en) 2015-04-20 2016-10-21 Commissariat Energie Atomique "ELECTRONIC DEVICE FOR MEASURING AT LEAST ONE ELECTRICAL CHARACTERISTIC OF AN OBJECT"
RU2713396C2 (en) * 2015-06-03 2020-02-05 Иллюмина, Инк. Compositions, systems and methods for sequencing polynucleotides using connective structures attached to polymerases located near nanopores
JP7166586B2 (en) * 2015-06-25 2022-11-08 ロズウェル バイオテクノロジーズ,インコーポレイテッド Biomolecular sensor and method
EP3332033B1 (en) * 2015-08-06 2021-04-21 Pacific Biosciences of California, Inc. Single-molecule nanofet sequencing systems and methods
WO2017027518A1 (en) * 2015-08-10 2017-02-16 Stratos Genomics, Inc. Single molecule nucleic acid sequencing with molecular sensor complexes
WO2017041056A1 (en) 2015-09-02 2017-03-09 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
CN108350017B (en) * 2015-09-10 2022-03-15 豪夫迈·罗氏有限公司 Polypeptide-labeled nucleotides and their use in nucleic acid sequencing by nanopore detection
JP2018533935A (en) 2015-10-08 2018-11-22 クオンタムバイオシステムズ株式会社 Nucleic acid sequencing apparatus, system and method
WO2017123416A1 (en) 2016-01-14 2017-07-20 Roswell Biotechnologies, Inc. Molecular sensors and related methods
EP3408219B1 (en) 2016-01-28 2022-08-17 Roswell Biotechnologies, Inc Massively parallel dna sequencing apparatus
KR20180105699A (en) 2016-01-28 2018-09-28 로스웰 바이오테크놀로지스 인코포레이티드 Methods and apparatus for measuring analytes using large scale molecular electronic device sensor arrays
EP3882616A1 (en) 2016-02-09 2021-09-22 Roswell Biotechnologies, Inc Electronic label-free dna and genome sequencing
US10597767B2 (en) 2016-02-22 2020-03-24 Roswell Biotechnologies, Inc. Nanoparticle fabrication
WO2017151680A2 (en) 2016-02-29 2017-09-08 Dodo Omnidata, Inc. Methods, compositions, and devices for information storage
US10883140B2 (en) 2016-04-21 2021-01-05 President And Fellows Of Harvard College Method and system of nanopore-based information encoding
JP2019524385A (en) 2016-05-19 2019-09-05 ドラゴン メディカル ディベロプメント リミテッドDragon Medical Development Limited Guidewire device and method for multi-parameter analysis of coronary stenosis
US20180014786A1 (en) 2016-07-15 2018-01-18 Dragon Medical Development Limited Multi-spline, multi-electrode catheter and method of use for mapping of internal organs
US9829456B1 (en) 2016-07-26 2017-11-28 Roswell Biotechnologies, Inc. Method of making a multi-electrode structure usable in molecular sensing devices
KR102526825B1 (en) 2016-08-01 2023-04-27 로스웰 바이오테크놀로지스 인코포레이티드 Modified Nucleotide Triphosphates for Molecular Electronic Sensors
WO2018098286A1 (en) 2016-11-22 2018-05-31 Roswell Biotechnologies, Inc. Nucleic acid sequencing device containing graphene
WO2018132457A1 (en) 2017-01-10 2018-07-19 Roswell Biotechnologies, Inc. Methods and systems for dna data storage
KR102601324B1 (en) 2017-01-19 2023-11-10 로스웰 바이오테크놀로지스 인코포레이티드 Solid-state sequencing devices containing two-dimensional layer materials
US10508296B2 (en) 2017-04-25 2019-12-17 Roswell Biotechnologies, Inc. Enzymatic circuits for molecular sensors
WO2018200687A1 (en) 2017-04-25 2018-11-01 Roswell Biotechnologies, Inc. Enzymatic circuits for molecular sensors
EP3622086A4 (en) 2017-05-09 2021-04-21 Roswell Biotechnologies, Inc Binding probe circuits for molecular sensors
WO2019046589A1 (en) 2017-08-30 2019-03-07 Roswell Biotechnologies, Inc. Processive enzyme molecular electronic sensors for dna data storage
WO2019075100A1 (en) 2017-10-10 2019-04-18 Roswell Biotechnologies, Inc. Methods, apparatus and systems for amplification-free dna data storage
US20200393440A1 (en) 2019-04-05 2020-12-17 Roswell Biotechnologies, Inc. Method, apparatus and system for single-molecule polymerase biosensor with transition metal nanobridge

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11621345B2 (en) * 2018-08-14 2023-04-04 Pawan Tyagi Systems and methods of fabricating gate electrode on trenched bottom electrode based molecular spintronics device

Also Published As

Publication number Publication date
KR20240122598A (en) 2024-08-12
WO2018200687A1 (en) 2018-11-01
US20200157595A1 (en) 2020-05-21
US11268123B2 (en) 2022-03-08
KR20200002897A (en) 2020-01-08
EP3615685A1 (en) 2020-03-04
CA3057151A1 (en) 2018-11-01
US20220002777A1 (en) 2022-01-06
CN110546276A (en) 2019-12-06
EP3615685A4 (en) 2021-01-20
KR102692957B1 (en) 2024-08-06

Similar Documents

Publication Publication Date Title
US10913966B2 (en) Enzymatic circuits for molecular sensors
US11268123B2 (en) Enzymatic circuits for molecular sensors
US11143617B2 (en) Binding probe circuits for molecular sensors
Liu et al. Single‐molecule detection of proteins using aptamer‐functionalized molecular electronic devices
JP5743974B2 (en) Nanotube sensor device for DNA detection
CN112384296B (en) Devices, systems and methods for direct electrical measurement of enzymatic activity
US20220098635A1 (en) Bioelectronic circuits, systems and methods for preparing and using them
JP2022517952A (en) Conductive synthetic peptides for molecular electronics
CN116018413A (en) Bioelectronic device with programmable aptamer
WO2023086653A2 (en) A molecular sensor and methods for use
WO2023167937A2 (en) Peptide based bridges for molecular sensors and methods for use thereof
WO2024054632A2 (en) N-terminal multifunctional conjugation of proteins and peptides for biosensing
WO2023089569A1 (en) Directly functionalized electrochmical transisteors, and convection driven ultra-rapid detection of biomarkers using transistors

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: WESTERN ALLIANCE BANK, AN ARIZONA CORPORATION, CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:ROSWELL BIOTECHNOLOGIES, INC.;REEL/FRAME:061150/0104

Effective date: 20211101

AS Assignment

Owner name: PROCOPIO, CORY, HARGREAVES & SAVITCH LLP, CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:ROSWELL BIOTECHNOLOGIES, INC.;REEL/FRAME:063601/0105

Effective date: 20221208

AS Assignment

Owner name: ROSWELL ME INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROSWELL BIOTECHNOLOGIES, INC.;REEL/FRAME:064073/0448

Effective date: 20230622

AS Assignment

Owner name: ROSWELL ME INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:PROCOPIO, CORY, HARGREAVES & SAVITCH LLP;REEL/FRAME:065474/0214

Effective date: 20221230